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Abstract 
Microorganisms colonizing the body of mammals are not only responsible for infectious 
diseases, they are also a very important factor for maintaining health. Commensal bacteria 
have a direct influence on health, as they compete with pathogens and can prevent them 
from colonizing. Additionally microorganisms have a more indirect influence: The gut 
microbiota is involved in development and shaping of the immune system, therefore 
dysbiosis may result in disease development. Within the last decade, many different 
diseases have been associated with a shift in the gut microbiota. Most studies however do 
not answer the question whether changes of the intestinal microbiome are cause or result of 
disease. As a mouse model, we used Rag1-/- mice, lacking B- and T-cells. An immune reaction, 
and therefor colitis development, is only possible after T-cell transfer. Depending on the 
composition of the gut microbiome at the time of T-cell transfer, the mice subsequently 
remain healthy or develop colitis. Changing the microbiome of the mice prior to 
reconstitution of the immune system influences disease development.  
Analysis of the intestinal microbiome can be done using different methods, such as PCR, FISH 
or by culture. However, these methods are limited to microorganisms, of which the genome 
sequence is known or that can be grown in the lab. These limitations can be overcome by 
using Next-Generation-Sequencing (NGS) to identify the members of the gut microbiome. 
Therefore, here we developed protocols for analyzing the intestinal microbiome from fecal 
samples.  
Our results show, that environmental factors influence the composition of the intestinal 
microbiome severely. Differences between single experiments were often greater than the 
differences between different treatments making it impossible to link a single or 
combination of bacterial species to induction of colitis or maintenance of health. For 
identifying microbiota compositions that are causative for health or disease, these 
environmental influences have to be eliminated or at least reduced. Otherwise the strong 
variations between animals will cover up causative alterations. 
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IX 
Zusammenfassung 
Mikroorganismen, die den Körper von Säugetieren besiedeln, sind nicht nur für Infektionen 
verantwortlich, sondern auch unerlässlich für deren Gesundheit. Kommensale Bakterien 
können unsere Gesundheit auf direktem Weg beeinflussen, z.B. vermitteln so eine 
Kolonisierungsresistenz indem sie mit Pathogenen kompetitieren und somit diese 
verdrängen können. Zusätzlich beeinflussen Mikroorgansimen die Gesundheit des Wirts auf 
indirektem Wege: Darmbakterien sind  an der Schulung und Entwicklung des Immunsystems 
beteiligt. Kommt es zur Dysbiose, kann das somit zur Entwicklung von Krankheiten führen. 
Im letzten Jahrzehnt wurden zahlreiche Erkrankungen mit einer veränderten 
Zusammensetzung des Darmmikrobioms assoziiert. Die meisten Forschungsarbeiten geben 
allerdings keinen Hinweis darauf, ob das veränderte Darmmikrobiom Ursache oder Wirkung 
einer Erkrankung ist. Um dieser Frage nachzugehen, haben wir als Modelorganismus Rag1-/- 
Mäuse verwendet. Diesen Tieren fehlen sowohl reife B- wie auch T-Zellen. Eine Kolitis kann 
sich nur dann entwickeln, wenn das Immunsystem durch einen T-Zell Transfer 
wiederhergestellt wurde. Somit kann die Zusammensetzung des Darmmikrobioms vor 
Krankheitsbeginn analysiert und verändert werden. Je nach Zusammensetzung des 
Darmmikrobioms zum Zeitpunkt des T-Zell Transfers, entwickelte sich eine Kolitis oder die 
Mäuse blieben gesund. Durch verändern der Ausgangszusammensetzung, konnten wir 
beeinflussen, ob eine Maus gesund bleibt oder erkrankt. 
Die Zusammensetzung des Darmmikrobioms kann mit Hilfe von Methoden wie PCR, FISH 
oder durch Kultivierung bestimmt werden. Der Nachweis von Bakterien über diese 
Methoden ist allerdings auf die Stämme beschränkt, deren Genomsequenz bekannt ist, bzw. 
die im Labor angezüchtet werden können. Die Protokolle, die in dieser Arbeit etabliert 
wurden, umgehen diese Beschränkungen, indem das Darmmikrobiom mit Hilfe von Next-
Generation-Sequencing von DNA aus Stuhlproben charakterisiert wird.  
Unsere Ergebnisse legen nahe, dass Umwelteinflüsse das Darmmikrobiom stark 
beeinflussen. Somit sind Unterschiede zwischen den Tieren verschiedener Experimente 
meist größer als Verschiebungen, die sich aufgrund unterschiedlicher Behandlungen oder 
Krankheitsstadien ergeben. Es ist daher unmöglich einzelne oder eine Gruppe von Bakterien 
zu identifizieren, die dafür verantwortlich sind, dass eine Kolitis entsteht bzw. ein Tier 
gesund bleibt. Untersuchungen dieser Art, können nur dann zu einer Assoziation zwischen 
Darmmikrobiom und Gesundheitszustand führen, wenn möglichst alle Umwelteinflüsse 
identisch sind. Ist dies nicht der Fall, verschleiern die individuellen Unterschiede jene, die mit 
einer Erkrankung im Zusammenhang stehen. 
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1. Introduction 
1.1 Microbiota and microbiome 
Microorganisms are present in various environments and habitats to which they have 
adapted over time. Some are able to survive under extreme conditions which are lethal for 
other organisms. The microbial compositions are just as diverse as their natural habitats, 
ranging from terrestrial hot springs to various human body sites 1–7. 
The community of microorganisms within a particular environment is referred to as 
microbiota. The organisms contributing to such a collective include not only bacteria, viruses 
and fungi but also archaea, phage and other microbial eukarya, however, bacteria are the 
most studied group 8. In 2001, Lederberg defined the term “microbiome” to describe the 
entirety of microorganisms colonizing the human body including symbiotic as well as 
pathogenic microorganisms 9,10.  
The human body is composed of approximately 1013 cells. It is estimated that about 10 times 
more bacteria, belonging to at least 500 different species, colonize the surfaces of a human 
and the majority of these are located in the gastrointestinal tract (GIT) 11–14. Taken together, 
these bacteria contain approximately 100-150 times more genes than a human 15–18. 
The amount and diversity of bacteria differ greatly between body sites. Whereas 
communities of the oral cavity and stool have been found to be very complex, vaginal 
communities are particularly simple 4,19.  
1.2 Intestinal microbiota 
The majority of the bacteria colonizing a human are located in the GIT. The microbiota of the 
different intestinal sections differs drastically in composition and amount of viable bacteria. 
Within the duodenum/jejunum the lowest counts (102 CFU/g content) have been detected 
(Figure 1). The number increases and reaches its maximum in the colon where 
1012 CFU/g content have been recorded 19–21. 
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Figure 1: Microorganisms (MO) mainly colonizing the different sections of the human intestinal tract 22. 
1.2.1 Development of an individual’s intestinal microbiota  
Depending on method of delivery, a newborn comes into contact with the vaginal as well as 
the intestinal microbiota of the mother and/or the microorganisms of the surrounding 
environment during childbirth. For many years this was considered to be the initial 
colonization and the beginning of a new microbial community 23–26. It has been recently 
hypothesized, however, that commensal intestinal bacteria of the mother translocate into 
the placenta and that the first contact takes place prior to birth 16,27. Post-partum newborns 
are also very quickly exposed to the microbiota of the maternal skin, milk and mouth 16.  
Breast milk, as a continuous source of bacteria, is one of the most important factors for the 
colonization of the neonatal intestinal tract 28,29. The relationship between this bacterial 
uptake and a child’s diet is strongly supported by the fact that the composition of the 
bacterial community colonizing the intestine differs between breast- and formula-fed 
children 26.  
The bacterial population changes drastically during the first years of life and constantly 
increases in diversity. Inter-individual variations are pronounced and significantly greater in 
young children than in adults. It is estimated that at approximately three years of age the 
intestinal microbial composition has reached a stable adult stage 16,30,31.  
The first bacteria to colonize the gastrointestinal tract of infants are facultative aerobic 
bacteria. After they have consumed the oxygen present in the GIT at birth, the changed 
environment then allows strictly anaerobic bacteria to reside and grow in the gut 16,26. The 
majority of, but not all, studies of the intestinal bacterial community of infants have 
detected dominating amounts of Bifidobacteria, which are considered “beneficial” for the 
health of the host 16,26,31,32. The adult intestinal microbiota, conversely, is dominated by 
bacteria belonging to the phyla of Bacteroidetes and Firmicutes 13,14.  
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1.2.2 Intestinal microbiota compositions and variations 
Microbiome studies indicate that the presence and abundance of bacterial species varies 
greatly between individuals; however, on a higher phylogenetic level it seems to be quite 
conserved 14. Eckberg et al. discovered approximately 400 different phylotypes belonging to 
7 phyla 13 within the human colon. The most abundant phyla are Bacteroidetes and 
Firmicutes. Together these two groups account for more than 90 % of the total bacteria, 
whereas others such as Proteobacteria, Actinobacteria, Fusobacteria and Verrucomicrobia 
are relatively rare 13,14. The strictly anaerobic intestinal environment may make it difficult for 
facultative anaerobic bacteria to successfully compete with Bacteroidetes and Firmicutes, 
resulting in them usually being present only in very low quantities 33. Inter-individual 
variations can partially be attributed to genetic factors of the host. It is also believed that the 
order in which bacteria colonize the intestine is important for the establishment of the gut 
microbiome. Bacteria shape the physiochemical properties of the colonized niche, which 
may or may not be advantageous to microorganisms that follow, thereby affecting the 
community assembly 34. 
The intestinal microbiota not only differs greatly between individuals, but also underlies 
smaller fluctuations within a single host 35. Due to these robust normal variations, 
pathological modulations may not be detected. In 2011, Arumugam et al. determined that 
although humans harbor varying microbial compositions in their intestines, people can be 
divided into one of three groups with different main contributing bacterial species. All 
studied subjects could be assigned to one of these main compositions. This indicates that 
non-pathological variations are not continuous but that the microbiome is restrained to 
certain well-balanced communities for symbiosis with the host 36.  
Correlating host properties with the microbial intestinal community by taxa is very difficult 
and in some cases, even impossible due to large variations. Although bacteria belong to 
different taxa, their genomes can code for the same or similar functional groups. Studying 
the genetic information of the microbiota on a functional level instead of only the taxonomic 
level, may decrease the perceived variations between and within individuals, allowing 
correlations to host properties 35,36. 
1.3 Interactions of intestinal microbiota and host 
The microbiota supports its host in many ways. Enhancing digestive efficiency by nutrient 
processing (germ-free animals need 30 % more calories 33), promoting proper immune 
system development and limiting pathogen colonization (colonization resistance) are only a 
few examples for the benefits the microbiota provides to the host 14,37–39. Mammalian 
genomes evolve rather slowly, and the faster evolving colonizing bacteria, can quickly take 
over functions that the host is unable to fulfill itself, for example, by supplying enzymes. 
Thus, by changing the microbial composition, otherwise impossible rapid adaptations to new 
circumstances are possible in mammals 33,40. In return, the microorganisms are given the 
advantage of living in a protected and nutrient-rich environment 15,19,33,41. The prerequisites 
for this symbiosis, however, are that the microbiota is accepted by the host, is limited to its 
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habitat and doesn’t penetrate host tissue. Commensal bacteria that fulfill these conditions 
are recognized by the host but do not induce a strong inflammatory reaction, in fact, some 
are even able to induce tolerance 33,42,43.  
Examples of factors suspected to influence the human microbiota include diet, antibiotic 
treatment, and exposure to environmental bacteria, 30,33,44–48. Similar bacteria support each 
other and increase the possibility of colonization of the host by related phylotypes 14. 
Influencing the microbiome by oral uptake of bacteria, e.g. by consumption of probiotics, 
may have beneficial effects to the host, if the correct bacterial subset is varied 49–51. The 
opposite, is also possible: certain bacterial community members can be reduced, for 
example by antibiotic treatment, minimizing the competition for space and nutrients for 
unaffected bacterial strains enabling these fractions to expand 52. In some cases, the 
weakened populations include beneficial bacteria that limit the ability of opportunistic 
pathogens to induce an immune reaction. The increase of pathogens and reduction of 
beneficial bacteria can result in manifestation of diseases, as in Clostridium difficile 
infection 52. 
1.3.1 Interaction of the intestinal microbiota and the host immune system 
The gut-associated lymphoid tissue (GALT) is important for the induction of an immune 
reaction after the identification of antigens. In addition to the organized lymphoid tissue of 
the GALT, the lamina propria of the gut wall harbors lymphocytes, which in addition to the 
architecture of the intestine also limit infection 53. 
The enormous amount of bacteria colonizing the gastrointestinal tract represents a high risk 
of infection for the host. The first line of defense against microbial penetration is the 
mucosal barrier including epithelial cells, and a mucus layer separating these cells from the 
gut lumen. Two strata are part of the mucus layer 33,54. The luminal layer contains bacteria 
whereas the inner layer is resistant to bacterial penetration in healthy individuals 33,55,56. This 
physical barrier, however, is not the only protection of the epithelial layer. Enterocytes and 
Paneth cells, which are part of the mucosa, protect the host from intestinal microbiota by 
separation of the deeper host tissue from the outside and by secreting antimicrobial 
peptides 33,57. These antimicrobial peptides are hindered from reaching the gut lumen by the 
mucosal layer 33,58, therefore selectively targeting bacteria threatening to penetrate host 
tissue. Further protection of the host is provided by the adaptive and innate immune 
systems, which constantly sample the gut microbiome and activate appropriate immune 
responses 33. Secretory immunoglobin A (SlgA) is essential for the host to receive 
information about the bacterial contents of the gut lumen 56. SIgA binds commensal bacteria 
and presents them to tolerogenic CD11c+ CD11b+ CD8- dendritic cells (DC) 56,59. This feature 
of SIgA is important for limiting inflammatory immune response towards commensal 
bacteria. The second important task of SIgA is to defend the host against invading 
pathogenic bacteria. SIgA recognizes and binds to pathogenic epitopes which eventually 
leads to the cross-linkage of these antigens, effectively preventing colonization by these 
species and reducing the inflammatory potential 56. 
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While the host must protect itself from some colonizing bacteria, others are essential for the 
development and shaping of the immune system 37,60–63. The importance of the intestinal 
microbiota can be seen in studies with germ-free animals, as these animals do not develop a 
fully competent immune system 37,63. 
The intestinal microbiota is involved in the development of different lymphocyte subsets. 
These induce the differentiation of pro-inflammatory TH17 effector T-cells 
33,64–67 and anti-
inflammatory regulatory FoxP3+ T-cells (Treg) 
64,68. By influencing the TH1 to TH2 ratio, the 
intestinal microbiota determines the outcome of systemic immune response 33,37. The 
structure of the LPS (Lipopolysaccharide) of intestinal bacteria is responsible for different 
TLR4 (Toll-like receptor 4) dependent signaling mechanisms which result in varying 
responses from the innate immune system 69. 
 
Figure 2: Architecture of the gut helps to defend the intestinal mucosal surface from microbiota [43]. 
Despite the architecture of the gut and constant interaction with the host immune system, 
bacteria of the microbiota can overcome the host protection mechanisms and induce 
pathological states. This can be either due to certain virulence factors of pathogens, for 
example, facilitating enhanced attachment of pathogens to the epithelium, or to the 
absence of bacterial products necessary for maintaining homeostasis. One such example is 
butyrate, an anti-inflammatory substance produced by bacteria of the gut microbiota. The 
short chain fatty acid (SCFA) butyrate is one of the main energy sources for the epithelial 
cells and is needed to maintain the tight junctions 70–73. If butyrate-producing bacteria are 
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missing, gaps occur between the epithelial cells, allowing increased translocation of antigens 
from the gut lumen into the host tissue. This phenomenon is referred to as “leaky gut” and 
leads to an immune reaction resulting in inflammation. SCFAs have been implicated in 
induction of Treg cell expansion, which is necessary for regulation of the inflammatory 
response of the immune system 74. 
The role of the intestinal microbiota has been discussed in the context of many different 
diseases. Stimulation of the host immune system and maintenance of the mucosal barrier 
seem to be primary issues in many of these diseases, as medical conditions, such as type 2 
diabetes or obesity, have been associated with general low grade inflammation and an 
altered gut microbiome75,76.  
1.4 Intestinal microbiota and disease 
During the past decade, studies have increasingly been able to associate the intestinal 
microbiota with a wide variety of diseases ranging from inflammatory bowel disease (IBD) 
and autoimmune diseases to cancer and mental disorders, as well as conditions like obesity 
20,35,44,49,73,77–81. Although these links have been made, no specific bacterial species have 
consistently been identified as causative for the medical conditions. Some fractions of the 
intestinal microbiota are considered to have high potential to trigger inflammation (e.g. 
E. coli 20,82–84), whereas others are less prone to induce inflammation, or even show the 
ability to counteract it (e.g. Lactobacillus, Bifidobacterium, Bacteroides vulgatus) 20,82. In 
addition to working against inflammation-inducing bacteria by decreasing the overall 
systemic inflammatory level, these beneficial fractions may also improve barrier effects of 
the intestinal mucosa, allowing less pathogen penetration into host tissue by pathogens, 
thereby reducing contact with the host’s immune system 85. Yet another possibility is that 
the anti-inflammatory bacteria directly interact with inflammation-driving components of 
the immune system to limit the immune response. These hypothesized actions may also 
intensify their effect by working simultaneously 51. Some diets and the consumption of 
probiotics aim to support the beneficial fractions of the intestinal microbiota 85.  
Diabetes is an example of a disease that has been associated with an altered intestinal 
microbiota 65,86,87. Individuals with type 2 diabetes have lower counts of Bifidobacterium and 
Faecalibacterium prausnitzii, whereas children suffering from type 1 diabetes show higher 
amounts of Clostridium, Bacteroidetes and Veillonella and lower amounts of Bifidobacteria 
and Lactobacilli. There is also greater bacterial diversity detected in the feces of healthy 
children 77. 
Autoimmune diseases, such as Type 1 Diabetes (T1D), Rheumatoid arthritis (RA) or multiple 
sclerosis (MS), have been associated with an altered intestinal microbiota 53,65,86,88,89. 
Although genetic predisposition plays an important role in T1D and RA, the low concordance 
rates in twins suggest that environmental factors strongly impact disease development 88,89. 
These autoimmune diseases are characterized by impaired Treg subsets and/or increased 
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number of autoreactive effector T-cells 89–91. This favors a proinflammatory immune 
response, which ultimately leads to tissue damage. 
Studies comparing the intestinal microbiota of healthy individuals and T1D patients 
discovered differences regarding Actinobacteria. Bacteroidetes, Proteobacteria, Firmicutes, 
Fusobacteria, Tenericutes, and Verrucomicrobia. Despite some disagreements, the 
conclusions drawn from the experiments are the same: carbohydrate metabolism and 
therefore the glycemic levels, are affected by the intestinal microbiome, and the decrease of 
butyrate-producing bacteria reduces mucin and the synthesis of tight junctions, leading to 
increased permeability of the gut and thus the induction of autoimmunity 65,86,91. 
In RA patients, Bifidobacteria and Bacteroides fragilis have been found to be reduced 92. 
Studies in mice have associated the intestinal microbiome with MS. Oral application of 
antibiotics reduced the onset and severity of EAE (experimental autoimmune 
encephalomyelitis) 93 and mice kept under germ-free conditions did not develop EAE, which 
is used as a model for MS, or only a mild form. Monocolonization of mice with segmented 
filamentous bacteria (SFB), on the other hand, is sufficient for inducing EAE 94,95. 
 
Other studies have shown that the intestinal microbiota of obese individuals contains fewer 
Bacteroidetes and more Actinobacteria and an overall lower diversity compared to the 
microbiota of lean subjects, findings on shifts of the amount of Firmicutes are controversial 
35,77,78 The same studies indicate that the microbiota affects the host; however, the lifestyle 
of the host also affects the microbiota. The bacteria of obese individuals are more effective 
in recovering energy from nutrients, therefore transplanting this microbiota into a lean host 
results in weight gain. On the other hand, if the host loses weight by dieting, the microbiota 
shifts to a composition resembling that of lean individuals 35.  
In general, it is hard to determine whether differences that are observed between diseased 
and healthy individuals should be considered as cause or effect, as the composition of the 
microbiota before and during disease development is unknown. In order to answer this 
question and to better understand normal variation in healthy individuals, an increasing 
number of prospective studies are monitoring the microbiota of individuals, some beginning 
immediately after birth 45,96–98. It is expected that different community compositions or 
community members that lead to disease development or can be used for diagnostics or 
therapy in the future will be identified.  
1.4.1 Inflammatory bowel disease (IBD) 
Inflammatory bowel disease (IBD) comprises two principal types of disease, Crohn’s disease 
(CD) and ulcerative colitis (UC). Symptoms experienced by patients of both include diarrhea, 
abdominal pain, rectal bleeding, fever, fatigue and weight loss 99. CD and UC are chronic 
relapsing inflammatory disorders affecting different parts of the gut. Typical disease onset is 
during young adulthood; however, 4 % of patients are diagnosed under the age of 5 (early-
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onset) or closer to the age of 60 (late onset) 44,100. These ages correlate with stages of life in 
which the diversity and stability of intestinal microbiota changes, reinforcing the hypothesis 
that the gut microbiota composition is involved in disease development 44,101. 
Although it is accepted that genetic predisposition plays an important role for the 
development of IBD, recent developments suggest that the intestinal microbiota and 
lifestyle of a person are also relevant factors 100,102–104. The immune system of IBD patients 
reacts inappropriately toward the intestinal microbiota 105. Different hypotheses exist on 
why the immune system overreacts toward the intestinal microbiota: 
1. The microbiota is quantitatively and qualitatively normal, but defective mucosal 
effector T-cells overreact or regulatory T-cells (Treg) do not react strongly enough to 
suppress the effector T-cell response 50,106. 
2. Defects of the immune system lead to inefficient bacterial clearance and therefore to 
the excessive stimulation of the immune system 44,107,108. 
3. The intestinal microbiome is disturbed, leading to either abnormal quantities or types 
of organisms colonizing the intestinal tract; the immune system is stimulated by the 
microbial shift 50,99. 
4. The mechanisms for the separation of intestinal bacteria and the host immune 
system are defective. This might be a result of destruction of epithelial barrier 
integrity due to microbial shifts and changes of the substances available to the host, 
or to decreased amounts of IgA and antimicrobial peptides 59,74,107,109,110.  
The role of the microbiota in IBD has been demonstrated by many human and animal 
studies. Animal models used for IBD research only develop disease when kept under non-
germ-free conditions. As soon as these predisposed animals are colonized with non-
pathogenic commensal microbiota, manifestation of IBD can be observed 50,111,112. The 
successful use of antibiotics and the treatment with probiotics to reduce intestinal 
microbiota and effectively treat IBD is another demonstration of this connection 112–117.  
IBD has often been associated with either an increase of Bacteroides species or 
Enterobacteria, and with a decrease of Firmicutes. Some studies also link the 
Bacteroides/Firmicutes ratio to development of inflammatory bowel disease 107,118–121. The 
reduction of one member of the phylum Firmicutes, Faecalibacterium prausnitzii (F. 
prausnitzii), has been associated with Crohn’s disease 121–124, although a study on pediatric 
Crohn’s disease observed the opposite result 125. F. prausnitzii and some other commensal 
bacteria that have been isolated from fecal samples are recognized as producers of short 
chain fatty acids (SCFAs) such as butyrate, which have been found to be reduced in IBD 
44,126,127. Butyrate provides most of the energy for the colonic enterocytes and is reported to 
be important for maintenance of the integrity of the mucosal barrier 34,107,128.  
In IBD patients, certain bacterial strains have not only been reported to vary in presence or 
quantity, but also the bacterial diversity of the intestinal microbiota have been found to be 
reduced in patients compared to healthy individuals 118,125,129. As has been found for other 
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variations of the microbiota in IBD patients contradicting publications also exist with respect 
to bacterial diversity 119.The changes of the intestinal microbiome that have been linked to 
IBD are summarized in Table 1. 
Table 1: Changes and their results that have been linked to IBD 44. 
Change in: Result: 
Microbial composition Decrease in α-diversity 
Decrease in Bacteroides and Firmicutes 
Increase in Gammaproteobacteria 
Presence of E. coli, specifically adherent- 
invasive E. coli 
Presence of Fusobacterium 
Decrease in Clostridia, Ruminococcaceae, 
Bifidobacterium, Lactobacillus 
Decrease in F. prausnitzii 
Microbial function Decrease in SCFAs, butyrate 
Decrease in butanoate and propanoate 
metabolism 
Decrease in amino acid biosynthesis 
Increase in auxotrophy 
Increase in amino acid transport 
Increase in sulfate transport 
Increased oxidative stress 
Increase in type II secretion system, secretion 
of toxins 
 
Despite the varying results regarding microbiota composition, the common theme is that the 
microbiota of IBD patients differs from that of healthy individuals 108. The question that 
remains is whether the altered microbiota is a cause or a result of dysbiosis. This can be 
studied best using animal models for IBD as the microbiota can be monitored before and 
after disease onset.  
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Various animal models exist, ranging from genetically modified animals with spontaneous 
disease development to erosive models in which inflammation is chemically induced, for 
example by the application of Dextran Sodium Sulfate (DSS), which mimics an acute infection 
130. Different animal models have been used to identify the different players, genetic 
predispositions, host immune systems and microbiota, driving IBD 103,104,131.  
Chronic inflammation is a result of a deregulated immune response; therefore, T-cell driven 
models seem to simulate human disease more accurately regarding to the immunological 
mechanisms responsible for the induction, perpetuation, and/or regulation of chronic 
disease 131. Reconstituting the T-cell population in recombinase activating gene 1 (Rag1) 
deficient mice which lack B- and T-cells, or in severe combined immunodeficient (SCID) mice, 
results in chronic inflammation of the colon within a few weeks after the transfer of naïve 
CD4+CD45high T-cell 132–135. 
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1.5 Next-Generation-Sequencing (NGS) 
The genomic DNA of all living organisms encodes their genetic information. It is the blueprint 
for all functions needed for development, survival and reproduction of a cell. An abundance 
of information about an organism can thus be obtained by studying the sequence of the 
genome. During the past decades many methodologies have been developed to achieve this.  
One of the first methods, therefore belonging to the “first generation” of sequencing, was 
Sanger Sequencing 136. It relies on a polymerase chain reaction (PCR) that is discontinued by 
the incorporation of a terminator nucleotide. This leads to DNA strands of various different 
lengths that are separated by electrophoresis. Each labeled (initially radioactive 136, 
fluorescent today 137) DNA strand results in a band according to its size. The terminating base 
of each band is known, so the sequence of the template DNA can be obtained by analyzing 
the pattern of the bands (Figure 3). 
 
Figure 3: DNA fragments generated during terminated PCR are separated according to size by polyacrylamide 
gel electrophoresis revealing the DNA sequence. 
Due to the Human Genome Project (HGP), which was initiated in the mid 1980’s, sequencing 
strategies were refined and new methods were tested. Whereas strategies based mainly 
upon Sanger Sequencing were used to complete the HGP 138, it inspired the development of 
completely new approaches for DNA sequencing. The achievements of this project were 
therefore not only the generation of the human genome sequence, but also new possibilities 
for large scale and high-throughput sequencing at constantly decreasing costs and 
manpower requirements, and increasing speed and accuracy 139. These new systems were 
summarized by the term “next-generation sequencing” (NGS). The first NGS system was 
launched in 2005 by the company 454 140 and quickly followed by others such as Solexa 141 
and Agencourt 142,143.  
These new sequencing methods are constantly being improved and have made it possible to 
sequence large amounts of DNA at low costs. This not only revolutionized the approaches of 
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studying basic biological mechanisms, but also provided the opportunity to use DNA 
sequencing in clinical diagnostics.  
In contrast to Sanger Sequencing, NGS platforms do not rely on electrophoretic separation of 
elongation terminated DNA strands produced in individual reactions; instead the DNA 
sequence is recorded in real-time during the extension of DNA molecules within one 
reaction [Review 11]. The template DNA molecules are spatially separated in a flow-cell and 
the systems can detect the sequences of extremely large numbers of different DNA 
molecules simultaneously, thus dramatically reducing processing time and enormously 
increasing the data output of each run.  
NGS platforms can be separated into systems that detect either the sequence of clonally 
amplified or single DNA molecules. Clonal amplification is achieved via different methods by 
each sequencing systems (Figure 4). For 454 pyrosequencing (454/Roche) and SOLiD 
(Agencourt/Applied Biosystems) for example, single molecules are captured on beads and 
amplified during emulsion PCR, resulting in beads covered with identical DNA molecules 140. 
Illumina/Solexa sequencing, on the other hand, relies on bridge PCR of a template DNA 
molecule immobilized on the surface of the flow-cell, generating clusters of DNA molecules 
with the same nucleotide sequence 144,145.  
 
Figure 4: DNA sequences are amplified during an emulsion PCR (A) for 454-Pyrosequencing and SOLiD 
technologies, or via bridge PCR (B) for Illumina sequencing 
Examples of systems based on the sequencing of single DNA molecules are the HeliScope 
(Helicos Biosciences) 146 and SMRT sequencing (Pacific Biosciences) 147. Unlike systems that 
require amplification of the DNA molecules, these systems avoid the introduction of 
potential errors during PCR, thereby reducing the sources of mistakes within the generated 
DNA sequence 148.  
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The specifications of the currently available NGS systems are outlined in Table 2; however, 
due to the rapid evolvement of the methods they are constantly changing, and accuracy and 
read lengths are always increasing. 
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Table 2: Specification of available sequencing platforms 
Platform Reagent Kit 
or 
Application 
Accuracy Read 
length 
Data 
output / 
run 
Sequencing 
mechanism 
Reads Time / 
run 
Quality Amplification 
method 
Advantages Disadvantages 
454 GS FLX GS FLX 
Titanium 
XL+ 
99,997 % Up to 
1000 bp 
700 Mb Pyrosequenci
ng 
149
 
~1 Million 
reads 
23 h  Emulsion PCR Long sequencing 
reads 
Error rate for 
polybases 
149
 
HiSeq 2500 v4 >80/85 % of 
bases 99,9 
% 
1 x 36 bp 
2 x 50 bp 
2 x 100 bp 
Or 
2x 125 bp 
Up to 500 
Gb 
Sequencing 
by synthesis 
149
 
Up to 4 
billion 
paired-
end reads 
6 days >85% of bases >Q30 at 
2×50 bp 
>80% of bases >Q30 at 
2×100 bp 
>80% of bases >Q30 at 
2×125 bp 
150
 
Bridge PCR High throughput 
149
 Short 
reads
149
 
MiSeq  v3  
 
>70/85 % of 
bases 99,9 
% 
2 x 75 bp 
2 x 300 bp 
Up to 15 
Gb 
Sequencing 
by synthesis 
Up to 50 
Million 
paired-
end reads 
55 h >85% bases >Q30 at 
2 x 75bp 
>70% reads >Q30
151
 
Bridge PCR High throughput 
149
 Short reads 
149
 
SOLiD  
5500 
System 
 99,99 % Mate-
paired: 2 x 
60 bp 
Paired-
end 75 bp 
x 35 bp 
Fragment 
75 bp 
Up to 160 
Gb 
Ligation and 
two-base 
coding 
149
 
Up to 1,4 
billion 
paired 
reads 
Up to 
7 days 
Greater than 80 % of 
bases ≥ QV 30 
Emulsion PCR Scalable throughput 
on single platform; 
multiple 
applications in one 
run 
Base calling is 
difficult 
Ion Torrent 
PGM 
Ion 318 
Chip v2 
98,29 %
152
 200 bp or  
400 bp 
Up to 2 
Gb 
Detection of 
pH 
differences 
Up to 5 
million 
reads 
4.4 h 
or 7.3 
h 
Mostly Q20
152
 Emulsion PCR  Biased 
coverage in 
AT-rich 
sequences
152
 
PacBio RS II  Depending 
on 
coverage; 
up to 99,999 
%
153
 
50 % of 
reads >20 
kb; 
maximum 
>60 kb
153
 
500 Mb – 
1 Gb
153
 
Sequencing-
by-synthesis 
About 
55,000 
reads
153
 
0,5 – 4 
h
154
 
QV 20 (single sequence, 
not consensus 
sequence) 
None Long reads, no prior 
amplification, 
Simultaneous 
Epigenetic 
Characterization 
Small 
amounts of 
reads 
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1.5.1 Applications of NGS: 
There are many applications for DNA sequencing, ranging from determination of the 
genomic DNA sequence of an organism to medical diagnostics. Depending on the question 
to be answered, some next-generation sequencing methods are more suitable than others. 
For example, if a bacterial genome has to be sequenced de novo, it is helpful to obtain long 
reads due to lack of reference genomes, whereas if the detection of rare bacterial species 
within a complex community is desired, a high coverage is of greater importance.  
Common applications for next-generation DNA sequencing are the analysis of entire 
genomes of organisms, targeted genomic resequencing to study polymorphisms or gene 
mutations for diagnostics, microbiome analysis, metagenomics, transcriptomics and 
identification of DNA-binding proteins or genomic methylation patterns 155. 
1.5.2 Studying microbial communities 
1.5.2.1 16S rRNA gene analysis 
In the past, the identification of bacteria was limited to species that could be cultured. Due 
to this restriction, only small portions of bacteria present in certain habitats were known and 
could be associated with specific environments. Of the human-associated microbiome, for 
example, it is estimated that, depending on the site of interest and taxonomic level, 
approximately 10 - 60% of the colonizing bacteria cannot be grown in culture 1–3,156–158. Next-
Generation sequencing removes the need to culture bacteria for identification, as this can 
now be done on the basis of the DNA sequence, and unculturable bacteria are not 
unintentionally excluded. 
The introduction of non-culture dependent identification methods rapidly increased the 
number of known bacterial species. During evolution some functionally important DNA 
fragments are conserved, whereas others evolve and rapidly acquire mutations. This enables 
the determination of relationships between bacterial species by analyzing DNA sequences, 
even if the actual taxonomy is unknown.  
One widely utilized gene for bacterial phylogenetic identification encodes the 16S subunit of 
ribosomes (16S rDNA) 159–161. The nucleotide sequence of the 16S rDNA encodes 9 variable 
regions, as well as regions that are highly conserved within all bacteria 162,163. By comparing 
these sequences, especially the variable regions, it is possible, with certain limitations, to 
determine the taxonomic classification and relationships between bacteria. Bacteria with 
sequence similarities greater than 99 % are considered to belong to the same strain; 97 % 
similarity is regarded as a species, 95 % as a genus, 90 % as a family and at least 80 % 
similarity is considered as a phylum 164,165.  
The approach in 16S metagenomics includes DNA isolation, amplification of the selected 16S 
rRNA gene regions, sequencing and data analysis (Figure 5). Each of these steps holds 
potential for biasing the result. Depending upon the DNA extraction method, isolation is 
more efficient from some bacterial species than others 166. Amplification of the 16S regions 
can produce chimeric sequences 167, sequencing errors can occur, and  bioinformatic analysis 
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is only as good as the reference databases used and may differ depending on threshold 
settings. For these experiments it is therefore essential to use the same methods for all 
samples that will be compared. 
 
Figure 5: The 16S metagenomics approach includes the steps: DNA isolation, sample preparation, sequencing 
and data analysis. Information is gained on taxonomic level. 
Analyzing the 16S rRNA gene gives information on the composition of the bacterial 
community within a sample. No conclusions can be drawn as to which biological tasks are 
taken over by these bacteria, however, or if and which other microorganisms are present in 
the studied environment.  
1.5.2.2 Shotgun metagenomics 
Using a shotgun metagenomic approach it is possible to study the entirety of genetic 
information present within a microbial community. In complex ecosystems it is not feasible 
to determine what genetic material originated from which organism; however, it is possible 
to study potential functional differences between samples. For this approach DNA is isolated 
from a sample and all the genetic material is sequenced. In contrast to 16S metagenomics, 
no DNA sequences are selected and amplified, rather the complete DNA is sheared into 
fragments of a defined length and attached to barcodes and sequencing adapters. The total 
DNA is then sequenced and the data compared to databases for functional and taxonomic 
assignment (Figure 6) 168,169. 
 
Figure 6: Shotgun metagenomic experiments include DNA isolation, sample preparation, sequencing and data 
analysis. Information is gained on a taxonomic and a functional level. 
Genome sizes vary between bacteria; Helicobacter pylori and Bacteroides thetaiotaomicron, 
for example, have genome sizes of 1.67 Mb and 6.3 Mb, respectively. Although the 16S rRNA 
gene (approximately 1500 bp) copy number ranges from 1 to 15 depending on bacterial 
species, the ribosomal RNA gene is outnumbered by other genes 170. The shotgun approach 
therefore gives information on the genes encoded by bacterial DNA and community 
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composition. Genes can be classified according to the function of the product encoded by 
the gene. Commonly used reference databases are KEGG, which maps enzymes onto 
metabolic pathways, and COG, which uses evolutionary relations to group genes according 
to related function 18. This approach enables the detection of all genes present in a 
metagenome, therefore giving information on all potential tasks carried out by the 
microbiome, but this does not necessarily mean that all the genes are transcribed and in use. 
1.5.2.3 Metatranscriptomics 
Bacteria transcribe different genes depending on the environmental conditions in which 
they live. Metagenomic analyses merely give information on which genes can potentially be 
used for certain biological tasks; metatranscriptomics, on the other hand, can give exact 
information on which genes are actually transcribed and “in use” 171. The expression profiles 
of different samples can be compared to identify specifically regulated genes and 
composition-independent functional alterations 172.  
In contrast to metagenomic approaches, for metatranscriptomic approaches, RNA is isolated 
instead of DNA. By reverse transcription using random primers, cDNA is created, which is 
sequenced and analyzed (Figure 7). For the comparison of expression profiles, the mRNA is 
of interest; however, it only contributes 1 – 5 % to total RNA 171. Various methods can be 
used for the enrichment of mRNA and reduction of rRNA although some researchers prefer 
to increase the number of sequences per read to minimize chances of biasing the results 
instead of enriching mRNA.  
 
Figure 7: Workflow metatranscriptomics. Total RNA is isolated from a sample and mRNA may be enriched. 
The RNA is reverse transcribed into cDNA, attached to barcode and linker sequences, sequenced and 
analyzed. 
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1.6  Scientific aim of this thesis 
Changes of the intestinal microbiota have been linked to many diseases, including IBD, in 
publications describing alterations of the composition of the microbiota colonizing the 
intestine of humans. Although some changes have been associated with disease, it is unclear 
whether alterations induce disease development or if the modified conditions within the 
inflamed gut lead to the shifts. To answer this question, the microbiota has to be defined 
before disease onset and during disease development.  
The murine T-cell transfer model is helpful for these experiments; disease onset is clearly 
defined because it is triggered by T-cell reconstitution, allowing determination of the 
microbial composition colonizing the gut with and without the influence of inflammation. 
The first goal of this thesis was to establish a protocol using next-generation sequencing for 
the analysis of the intestinal microbiota from stool samples. The subsequent aim was to 
compare the microbiota in the T-cell transfer model to analyze the bacterial composition 
preventing or leading to development of colitis, as well as the changes induced by disease 
onset, and related to alterations of the environmental conditions. 
The development of IBD, however, may also be influenced by factors other than the 
bacterial composition of the intestinal microbiome. The colonization of the gut by other 
microorganisms including viruses and archaea could also impact IBD development; however 
these organisms are not detected by 16S rRNA gene-based microbiome analysis. In addition, 
tasks that can be performed by the microorganisms may also be relevant for the 
development of IBD. The functions performed by these microorganisms may be essential for 
the availability or removal of substances that are involved in maintaining homoeostasis or in 
the development of IBD. Establishing suitable methods of shotgun metagenomics to gather 
information about gut microorganism presence and function based upon their DNA was a 
further goal of this thesis.  
Shotgun metagenomics gives information on which tasks can be performed by the intestinal 
microbiota, but cannot reveal whether the tasks are actually carried out. Transcriptome 
analysis of a sample only includes transcribed genes, allowing conclusions to be drawn 
regarding which functions are carried out by the microorganisms colonizing the gut. To 
complete the analysis of the intestinal microbiome, the third goal of this thesis was to 
establish methods needed for metatranscriptome analysis.  
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2. Materials and Methods 
2.1 Materials 
 Mice  2.1.1
Table 3: List of mouse strains, vendors and housing 
Strain Supplier Animal housing 
C57BL/6Ola Hsd Harlan Winckelmann HNO (SPF) 
C57BL/6J Oberberghof Ulm Oberberghof Ulm (germfree) 
C57BL/6J-Rag1tm1Mom 
(Rag1-/-, EloBhi) 
Own breeding in FORS, red 
area 
HNO (SPF) 
C57BL/6J-Rag1tm1Mom 
(Rag1-/-, EhiBlo) 
Own breeding ETH (SPF) 
The C57BL/6J animals were bred and kept in isolators under germfree conditions at the 
animal facility Oberberghof in Ulm. In separate isolators at this animal facility animals were 
also mono- or co-colonized with E. coli mpk and/or Bacteroides vulgatus. 
C57BL/6Ola Hsd animals were obtained from Harlan Winckelmann at the age of 6-8 weeks 
and kept under conventional conditions at the animal facility in the ENT-clinic at the 
University Tübingen (animal facility “HNO”). The spleen of these animals was used to isolate 
naïve T-cells for transfer into Rag1-/- mice. 
The Rag1-/- mice were kept under specific pathogen free (SPF) conditions in isolated 
ventilated cages (IVC) in two different housing facilities of the University Tübingen (“HNO” 
and “ETH” (Einrichtung für Tierhygiene). 
The animal experiments took place according to the admissions H6/10 as well as the Anzeige 
§4 01.12.11, §4 13.07.12 and §4 19.12.08. 
 Antibodies for flow cytometry 2.1.2
Table 4: List of antibodies, Fluorophores, and vendors 
Antibody (Ordering 
Number) 
Fluorophore Clone Concentration Supplier 
FITC Hamster Anti-Mouse 
CD3e (553062) 
FITC 145 
2C11 
0.5 µg/µl BD 
Biosystems 
PerCp Rat Anti-Mouse CD4 
(553052) 
PerCp RM4-5 0.2 µg/µl BD 
Biosystems 
PE Rat Anti-Mouse CD4 
(553049) 
PE RM4-5 0.2 µg/µl BD 
Biosystems 
PE Anti-Mouse CD45RB  
(553101) 
PE 16A 0.2 µg/µl BD 
Biosystems 
Alexa Fluor 700 Rat Anti-
Mouse CD62L (560517) 
Alexa Fluor 
700 
MEL-14 0.2 µg/µl BD 
Biosystems 
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 Primers 2.1.3
Table 5: Specifications of primers used for PCR amplification 
454-sequencing library preparation 
Name Sequence 5’→3’ Supplier 
M13 338F 
GTAAACGACGGCCAGTGCTCCTACGGG
WGGCAGCAGT 
biomers.net 
revM13 1044R 
GGAAACAGCTATGACCATGACTACGAG
CTGACGACARCCATG 
biomers.net 
B_revM13 
CTATGCGCCTTGCCAGCCCGCTCAG-
GGAAACAGCTATGACCATGA 
Eurofins MWG Operon 
Forward primer 
(Linker+Barcode+
M13 338F) 
CGTATCGCCTCCCTCGCGCCATCAG-
Barcode (Table 20)- 
GTAAACGACGGCCAGTG 
Eurofins MWG Operon 
qPCR 
Name Sequence 5’→3’ Supplier 
uniF340 ACTCCTACGGGAGGCAGCAGT biomers.net 
uniR514 ATTACCGCGGCTGCTGGC biomers.net 
Bact-F285 GGTTCTGAGAGGAGGTCCC biomers.net 
Univ-R338 GCTGCCTCCCGTAGGAGT biomers.net 
EcoliF395 CATGCCGCGTGTATGAAGAA biomers.net 
EcoliR470 CGGGTAACGTCAATGAGCAAA biomers.net 
qPCR B.v.+B.d. F TCCATACCCGACTTTATTCCTT Eurofins MWG Operon 
qPCR B.v.+B.d. R ACTCCTACGGGAGGCAGC Eurofins MWG Operon 
 
The lyophilized primers were resuspended in ultrapure water (Braun) to a stock 
concentration of 100 µM. Aliquots of the stocks were stored at -20 °C, and working stocks 
were diluted to a concentration of 10 µM. 
 Hardware and software 2.1.4
BiodocAnalyze Ti5 (Biometra) 
BD LSRFortesse (BD Bioscience) 
BD FACSDiva software (BD Bioscience) 
FlowJo (Tree Star Inc., USA) 
Bioanalyzer 2100 (Agilent) 
2100 Expert software (Agilent) 
MEGAN5 software Version 5.2.3 173  
Qiime174 
Lightcycler 480 (Roche)  
Lightcycler 480 SW1.5 software (Roche) 
Leica DMRE microscope (Leica) 
Zeiss CLSM 710 NLO (Zeiss) 
Zen software (Zeiss) 
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2.2 Methods 
 Cultivation of bacteria 2.2.1
Aerobic or facultative anaerobic bacteria such as E. coli JM83 were cultivated in 5 ml Luria-
Bertani (LB) medium, and E. coli JM83 htrBhtrBpg in 5 ml LB medium supplemented with 
0.1 % Ampicillin. Cultures were incubated over night at 37 °C on a shaker at 200 rpm, and 
were subsequently used to inoculate 50 ml of LB media which was then incubated for 
another 3-4 hours.  
Anaerobic bacteria such as B. vulgates mpk were cultivated in soya broth containing liver 
pieces at 37 °C under anaerobic conditions for two days. The broth was then transferred to 
100 ml brain heart infusion (BHI) medium and incubated for another 2 days. 
Bacteria grown in liquid culture were harvested by centrifugation at 4000 g for 5 min and the 
supernatant was discarded. 
 DNA Isolation from bacterial culture 2.2.2
DNA was isolated from bacterial cultures using the Genomic-tip 100/G Kit (Qiagen). Buffers 
were prepared according to the specifications given in the Genomic-DNA Handbook. 
Following the manufacturer’s protocol, pelleted bacteria or bacteria grown on plate were 
resuspended in 3.5 ml Buffer B1 containing RNase A (0.2 mg/ml). Eighty µl of lysozyme (100 
mg/ml; Sigma) and 100 µl of Proteinase K stock solution (Qiagen) were added to the sample 
prior to incubation for 30 min at 37 °C. After bacterial lysis, 1.2 ml of Buffer B2 were added 
for deproteinization. The tube was inverted several times to ensure complete mixture of the 
compounds and incubated at 50 °C for 30 minutes. If the lysate was not clear the incubation 
time was extended or the particles were pelleted by centrifugation and the supernatant was 
transferred into a new tube. 
A Genomic-tip 100/G column was equilibrated with 4 ml of Buffer QBT, after which the flow-
through was removed. The sample was vortexed for 10 seconds and then applied to the 
column, through which it passed by gravity flow. If liquid remained in the column, slight 
positive pressure was applied. The column was washed twice using 7.5 ml of Buffer QC each 
time. The genomic DNA was eluted by the addition of 5 ml Buffer QF and subsequently 
precipitated by mixing with 3.5 ml of isopropanol (Merck). If the precipitated DNA was 
visible, it was spooled with a glass rod, transferred into 100 µl Buffer TE, and dissolved on a 
shaker at 55 °C for 1-2 hours. Alternatively, the DNA was pelleted by centrifugation at 5000 g 
for 15 min at 4 °C, washed in 3 ml of cold 70 % ethanol and again centrifuged at 5000 g for 
10 min at 4 °C. The supernatant was discarded and the DNA resuspended in 100 µl Buffer TE 
as described earlier. 
The genomic DNA was stored at -20 °C. 
Gel electrophoresis of the isolated DNA showed that the Genomic Tip 100 kit yielded high 
quality, non-degraded genomic DNA (Figure 8).  
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Figure 8: Non-degraded, genomic bacterial DNA isolated using the Genomic Tip 100 kit (Qiagen). 
 Fluorescence in Situ Hybridization (FISH) 2.2.3
2.2.3.1 Sample fixation 
2.2.3.1.1 Fecal samples 
Fecal samples were resuspended in 1 ml 4 % PFA and stored at 4 °C for 2-4 hours. The PFA 
was removed by centrifugation for 5 min at 4000 g and the pellet was washed with 1 ml 
of PBS. After a second centrifugation step, the supernatant was discarded and the pellet was 
resuspended in 1 ml of 60 % ethanol and stored at –20 °C. 
2.2.3.1.2 Bacterial cultures 
Bacteria grown on an agar plate were suspended in PBS, resulting in visible clouding. 300 µl 
of the bacterial suspension was mixed with 900 µl 4 % PFA and incubated at 4 °C for 4 hours. 
After incubation, the bacteria were pelleted by centrifugation for 5 min at 11000 g. The 
supernatant was removed and the pellet was washed with 1 ml PBS followed by 
centrifugation for 5 min at 11000 g. Again the supernatant was removed and the pellet was 
resuspended in 150 µl 60 % ethanol. 
Samples were stored at -20 °C. 
2.2.3.2 Sample staining 
5 µl of samples, fixed as described in 2.2.3.1 Sample fixation, were pipetted onto a slide. 
After samples dried they were dehydrated by placing the slide into a reaction tube filled with 
50 % ethanol for 3 min and then transferred into 80 % and 100 % ethanol each for another 3 
minutes. The slide was dried before the FISH probes (Table 6) were added to the sample.  
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Table 6: Sequences and flourophores of FISH probes 
Name Sequence 5’→3’ Fluorophore Supplier 
Bac sp. 
AF488175 
AF488-CCAATGTGGGGGACCTT AlexaFluor 488 Eurofins MWG Operon 
Ent-CY382 Cy3-CCCCCWCTTTGGTCTTGC Cy3 Metabion 
Bvul-
Fluo82 
Fluo-TCCATACCCGACTTTATTCCTT Fluorescein Metabion 
Eub338-
Cy5176 
Cy5-GCTGCCTCCCGTAGGAGT Cy5 Metabion 
Bac_spp-
Fluo175 
Fluo-CCAATGTGGGGGACCTT Fluorescein Metabion 
B. 
vulgatus-
Cy382 
TCCATACCCGACTTTATTCCTT-Cy3 Cy3 Metabion 
The probes were mixed with freshly prepared ready-to-use hybridization buffer (Table 7).  
Table 7: Buffers used for fluorescence in situ hybridization 
Prepared hybridization buffer (Stored at 4 
°C) 
56 ml 5 M NaCl 
6.25 ml 1 M Tris-HCl pH8 
187.5 ml H2O 
Ready-to-use hybridization buffer 1600 µl prepared hybridization buffer 
2 µl 10% SDS 
400 µl Formamide 
Prepared washing buffer (Stored at 4 °C) 45 ml 5 M NaCl 
20 ml 1 M Tris-HCl pH8 
Adjust to 1L with H2O 
Ready-to-use washing buffer 100 ml prepared buffer 
100 µl 10% SDS 
For each sample, 10 µl of the hybridization buffer/probe mix was used. The mix contained 1 
µl of each probe. Ready-to-use hybridization buffer was added to the probes to a total 
volume of 10 µl per sample. 
Approximately 1 ml of hybridization buffer was used to moisten a filter paper in the 
hybridization chamber. The slide was stored in the hybridization chamber in the dark at 
46 °C for at least 1 hour. After hybridization, the slide was washed with preheated washing 
buffer (46 °C), and subsequently stored in the washing buffer for 15 min at 46 °C. To avoid 
unspecific binding the slide was rinsed with ice cold purified water immediately after 
removing it from the washing buffer. The samples were dried, covered with 10 µl DAPI 
(1µg/ml; Merck) and stored at 4 °C for 5 min. The DAPI was rinsed off with ice cold water 
and the slide was dried at room temperature. Mowiol 4-88 (CALBIOCHEM, prepared 
according to manufacturer’s instructions) was used to conserve the samples and for 
mounting the cover slip. 
Slides were stored in the dark at 4 °C. 
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A Leica DMRE microscope was used for visualizing the staining of bacteria with the filters 
listed in Table 8. 
Table 8: Filters for Leica DMRE microscope; BP= bandpass filter, LP = longpass filter 
Filter 
Excitation 
Range 
Excitation 
Filter 
Dichromatic 
Mirror 
Suppression 
Filter 
I3 blue BP 450-490 510 LP 515 
N2.1 green BP 515-560 580 LP 590 
G/R 
blue 
BP 490/20; 
575/30 
505;600 
BP 525/20; 
635/40 
Y5 red BP 620/60 660 BP 700/75 
A UV BP 340-380 400 LP 425 
K3 blue BP 470-490 510 LP 515 
 Real-time PCR  2.2.4
Isolated DNA was mixed with reagents for quantitative real-time PCR (qPCR) as listed in 
Table 9 and amplified according to the thermocycler protocol shown in Table 10. The 
amount of total bacteria within a sample was measured to provide a reference and allow for 
the normalization of different samples for comparison. The bacteria detected using specific 
primers were calculated as proportion of the total amount of bacteria using the following 
formula: 
𝐴𝑚𝑜𝑢𝑛𝑡𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐
𝐴𝑚𝑜𝑢𝑛𝑡𝑇𝑜𝑡𝑎𝑙
=
𝐸𝑐𝑡𝑇𝑜𝑡𝑎𝑙 
𝐸𝑐𝑡𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐
 
Table 9: Components for qPCR 
Reagent Amount Supplier 
2 x QuantiFast SYBR Green PCR 
Master Mix 
12.5 µl Qiagen 
Forward primer (10 mM) 2 µl Primer 
dependent 
Reverse primer (10 mM) 2 µl Primer 
dependent 
Ultra pure water 8.5- x Invitrogen 
DNA 50 ng (x µl)  
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Table 10: Thermocycler profile for quantitative real-time PCR 
Phase 
Target 
temperature 
[°C] 
Duration Cycles 
Ramp rate 
[°C/sec] 
Acquisitions 
Denaturation 95 5 min  2  
Program 
95 10 sec 
40 
4.4  
60 30 sec 2.2 Single 
Melting 
95 5 sec  4.4  
46 10 sec  2.2  
95  
 0.06 Continuous; 10 
acquisitions per °C 
increase  
Cooling 40   2.2  
The specificity of PCR primers was tested in silico by comparing the primer sequences with 
the NCBI nucleotide collection (nr/nt) database using blastn and Primer-BLAST. The ability of 
the primers to amplify DNA from bacterial strains other than the one of interest was also 
assessed experimentally. The set of bacteria listed in Table 11 were selected for covering as 
many different phyla as possible known to colonize the mouse intestine. 
Table 11: Experimental assessment of primer specificities with various bacteria from different phyla to minimize the 
probability of false positive results. 
Bacteria Tested 
E. coli 
Primer 
(EcoliF395 
+ 
EcoliR470)
Bacteroidales 
(BactF285 + 
UnivR338)
B. vulgatus & 
B. dorei 
(qPCR Bv & Bd F + 
qPCR Bv &Bd R)
Bacteria 
(uniF340 
+ 
uniR514)
Bacteria 
(M13 388F + 
revM13 
1044R)
B. dorei     
B. fragilis     
B. subtilis     
B. 
thetaiotaomicron 
    
B. vulgatus     
C. difficile     
E. cloacae     
E. coli JM83     
E. durans     
E. faecalis     
E. gallinarum     
K. pneumonia     
L. casei     
P. aeruginosa     
P. bivia     
S. aureus     
S. epiderimdis     
S. pneumonia     
S. thermophilus     
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The primers were subjected to further evaluation for usability in quantitative real-time PCR 
(qPCR). Three defined dilutions of the template DNA were generated and amplified. The 
different ct (threshold cycle) values resulting from the varying amount of DNA added to the 
reactions were used for simple linear regression. The slopes of the fitted lines resembled the 
amplification efficiency of the primer sets and are listed in Table 12. 
The melting curve of the primers was assessed to exclude unspecific DNA amplification. 
None of the three primer pairs evaluated for qPCR showed evidence of random primer 
binding. Figure 9 displays the melting curve of the universal bacterial primer pair after 
amplification of DNA extracted from the bacteria listed in Table 11.  Figure 9 also presents 
the melting curves of the E. coli and B. vulgates/B. dorei specific primers. The only 
differences were the melting temperatures, which varied between 80 °C and 85 °C. 
 
Figure 9: Melting curve recorded during qPCR of bacterial DNA amplified by universal bacterial primer uniF340 and 
uniR514. 
The amount of E. coli and B. vulgatus / B. dorei present in the intestine could be monitored 
by analyzing fecal samples. As expected, mice treated with antibiotics accommodated fewer 
bacteria than untreated mice and E. coli fed mice (Figure 10). The difference in B. vulgatus 
quantities before and after feeding of bacteria was also evident. 
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Figure 10: Amplification of bacterial and E. coli DNA extracted from the feces of an untreated mouse (blue), after antibiotics 
treatment (green) and feeding of E. coli JM83 (red). 
The proportion of each specific species was calculated by combining the species-specific 
information with that of total bacteria (2.2.4 Real-time PCR). The percentage of E. coli 
colonizing untreated mice was 0.0018 %. After the feeding of E. coli JM83, the total bacterial 
load increased, as did the proportion of E. coli (0.0033 %). Streptomycin treatment reduced 
the total amount of bacteria, however the relative E. coli amount increased to 0.0043 %. The 
same tendencies were observed in animals fed with E. coli JM83 htrBhtrBPG. The increase 
of B. vulgates in the stool after the oral application of antibiotics was also detectable by 
qPCR. 
Table 12: Amplification efficiencies of primers used for qPCR 
Primer set Efficiency 
E. coli (EcoliF395 +EcoliR470) 1.828 
B. vulgatus & B. dorei (qPCR Bv & Bd F +qPCR 
Bv &Bd R) 
1.956 
Bacteria (uniF340 + uniR514) 1.866 
 Identification of bacterial strains 2.2.5
For identification of single bacterial strains, they were grown on agar plates to ensure purity.  
2.2.5.1 Analyzing 16S gene fragments 
DNA was isolated from each bacterial culture by picking a colony from the agar plate and 
disrupting the cells by heating them for 5 min at 99 °C. The cell particles were separated 
from the DNA by short centrifugation. 1 µl of the DNA-containing supernatant was mixed 
with 10 µl 2x Dream Taq Master Mix, 1 µl M13 338F (10 µM), 1µl revM13 1044R (10 µM) and 
6.5 µl ultrapure water. The thermocylcler program used for amplification is described in 
Table 19. The amplicons created during the PCR were purified from the reaction mix using 
the Agencourt AMPure XP system (Beckman Coulter). A volume equaling 1.8 fold of the PCR 
volume of Agencourt AMPure XP was added, homogenized with the sample, and incubated 
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at room temperature for 5 min to ensure binding of the DNA to the magnetic particles. The 
sample was next placed onto a magnet; the magnetic particles accumulated close to the 
magnet and the cleared solution was discarded. The DNA was washed twice by the addition 
of, and after 30 sec, the removal of 200 µl 70 % ethanol (Merck). The reaction tube and the 
magnet were disassembled and the DNA was separated from the magnetic particles by the 
addition of 25 µl of AE Buffer (Qiagen). After thorough mixing, the sample was returned to 
the magnet and the cleared buffer containing the DNA was transferred into a new reaction 
tube. The DNA was prepared for sequencing according to GATC’s specifications and sent to 
GATC for Sanger Sequencing. The DNA sequence was compared by a standard nucleotide 
search of the NCBI nucleotide collection database for identification. 
Uncultured/environmental sample sequences were excluded from the search. 
2.2.5.2 Mass spectrometry 
Bacteria were identified through mass spectrometry using a MALDI-TOF-MS (Shimadzu) and 
were compared to the SARAMIS Database (Anagnostec) which contains commercially 
available spectra. They were also compared to spectra from other species which were added 
individually after verification by 16S sequencing. 
 Purification of DNA amplicons  2.2.6
PCR amplicons were purified using the Agentcourt AMPure XP system (Beckman Coulter). 
The volume of the PCR reaction was increased by 1.8 fold with AMPure beads and pipetted 
up and down until the solution was homogenous. After incubation at room temperature for 
5 min the sample was set on a magnet. The magnetic beads to which the DNA was bound 
accumulated next to the magnet. The cleared supernatant was removed approximately 
2 min after the samples were set onto the magnet. Residues of the PCR reaction mix were 
washed away during two washes of 70 % ethanol (Merck) using 200 µl each. The ethanol 
remained on the beads for 30 seconds. The sample was removed from the magnet and the 
DNA was dissociated from the beads by adding 25 µl AE buffer (Qiagen).  The sample was 
placed back onto the magnet for 1 minute, enabling the separation of the dissolved DNA 
from the beads. 
 Gel electrophoresis 2.2.7
Gel electrophoresis was used for DNA size separation and visualization. Samples were mixed 
with the loading buffer Orange G at a ratio of 6:1 and loaded onto a 1 % (for long amplicons) 
or 2 % (for short amplicons) agarose gel. The electrophoresis was carried out at 100 V for 
30-60 minutes. The DNA was visualized by staining with ethidium bromide (1.5 µg/ml; Roth) 
for 20 minutes, removal of unbound ethidium bromide with distilled water and 
documentation using the BioDocAnalyze Ti5 (Biometra). 
 DNA quantification 2.2.8
2.2.8.1 NanoPhotometer (Implen) 
The absorption of the elution buffer was used as a nucleic acid-free reference. The 
absorption of a sample was measured between 200 nm and 400 nm. The purity of a sample 
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was assessed by the ratio of the absorption at 260nm/230 nm; the DNA concentration was 
calculated from the 260 nm/280 nm ratio. 
2.2.8.2 Fluorometric measurement 
The Quant-iT™ High-Sensitivity DNA Assay Kit (Life Technologies) was used for fluorometric 
measurement of the DNA concentration.  
2.2.8.2.1 Measurement with the Infinit 200pro  
For each of the 8 standards and the samples to be measured, a volume of 100 µl Quant-iT 
dsDNA HS Buffer was mixed with 0.5 µl Quant-iT dsDNA HS Reagent and transferred into a 
well of a flat bottom 96 well microplate (Greiner). 10 µl of the standard or 1 µl of the 
samples were added and mixed thoroughly with the buffer. The absorption was measured 
using an Infinit 200pro (Tecan) with the settings listed in Table 13. The concentration of the 
DNA was calculated by using the DNA standard concentrations as a reference. 
Table 13: Fluorometer settings for measuring DNA concentrations using the Quant-iT High-Sensitivity DNA 
Assay Kit 
Option Setting 
Shaking (Linear) Duration: 3 sec 
Shaking (Linear) Amplitude: 1 mm 
Wait (Time) 5 sec 
Mode 
Fluorescence 
Top Reading 
Multiple Reads per Well (Square 
(filled)) 
2 x 2 
Multiple Reads per Well (Border) 250 µm 
Excitation Wavelength 504 nm 
Emission Wavelength 533 nm 
Excitation Bandwidth 9 nm 
Emission Bandwidth 20 nm 
Gain Optimal 
Number of Flashes 50 
Integration Time 150 µs 
Lag Time 0 µs 
Settle Time 0 µs 
Z-Position 
Calculated automatically from well  
containing the 10 µg/ml standard 
2.2.8.2.2 Measurement with the Qubit2.0 
For determination of the DNA concentration using the Qubit 2.0 (Life Technologies), 1 µl 
sample was mixed with 199 µl Quant-iT dsDNA HS Buffer containing 0.5 % Quant-iT dsDNA 
HS Reagent in a clear 0.5 ml reaction tube. 
 Bioinformatics 2.2.9
Analysis of the raw sequencing data received from Eurofins MWG Operon was completed by 
Hans-Joachim Ruscheweyh from the Department for Algorithms in Bioinformatics. The exact 
pipeline is described in his dissertation and is only outlined in Figure 11 177. 
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In the first step, sequences were demultiplexed, meaning the reads were assigned to the 
sample from which they originated. The sequences were next trimmed to remove the low 
quality tail of the sequencing reads. Further quality filtering was applied.  Data further 
analyzed using Qiime 178 were clustered into operational taxonomic units (OUTs). Sequences 
belonging to the same OTU have sequence similarities of at least 97 %. Taxonomic 
classification was done by RDP using a representative sequence of each OTU. 
For analyzing the data using MEGAN, the quality filtered sequences were aligned against the 
reference Silva database using MALT and imported into MEGAN for further analysis.  
Figure 11: Bioinformatics pipeline for analyzing sequencing data 
 Adoptive T cell transfer model 2.2.10
2.2.10.1 Isolation of CD4+ T cells from spleen 
The spleen of a C57Bl/6 mouse was extracted, transferred to 10 ml of PBS (Invitrogen) 
supplemented with 1 % FCS (Sigma) (PBS/FCS) and subsequently pressed through a mesh 
(100 µm). Cells were separated from PBS/FCS by centrifugation at 400 g at room 
temperature for 5 minutes. Erythrocytes were lysed by the addition of 3-5 ml of Lysis Buffer 
(155 mM NH4Cl, 10 mM KHCO3, 10 mM EDTA disodium salt) and incubated for 5 min at room 
temperature. After adding PBS/FCS to a total volume of 10 ml the cells were centrifuged at 
400 g for 5 min. Cells extracted from the spleen were washed with PBS/FCS and counted 
using a hemocytometer and trypan blue staining to exclude dead cells from count.  
Selection of naïve CD4+CD62L+ T-cells was performed using the “CD4+ T Cell Isolation Kit II, 
mouse” (Miltany Biotec). According to the manufacturer’s protocol, for each 1 x 107 cells 
isolated, 40 µl PBS/FCS and 10 µl biotinylated antibody mix were added and the mixture was 
incubated at 4 °C for 10 min. After the antibodies bound to the cells, for each 1 x 107 cells 
30 µl PBS/FCS and 20 µl of magnetic beads were added. This mixture was incubated for 
15 min at 4 °C. After incubation, PBS/FCS was added to a total volume of 10 ml and the 
cell/antibody/bead complex was separated by centrifugation for 10 min at 400 g. Next a 
MACS separation LS column (Miltany Biotec) was equilibrated using 3 ml PBS/FCS. One 
column was used for a maximum of 1 x 108 cells.  
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After centrifugation, the supernatant was discarded and the cells were resuspended in 1 ml 
PBS/FCS which was transferred to the prepared MACS separation LS column. Once the cell 
suspension passed through the column it was washed with 4 x 3 ml of PBS/FCS. The flow-
through contained the CD4+CD62L+ naïve T-cells, which were then pelleted by centrifugation 
for 5 min at 400 g. The supernatant was discarded and the number of living cells was 
determined as described earlier.  
The concentration of the cell suspension was adjusted to 5 x 106 T-cell/ml by adding PBS/FCS 
5 x 105 isolated T cells were transferred intraperitoneally (i.p.) into Rag1-/- mice. 
2.2.10.2 Purity and quality control 
At least 5 x 105 isolated T cells were used to verify the purity and quality. They were 
suspended in 1 ml CD16/CD32 (Fcγ III/II receptor; clone 2.4G2) antibody solution to avoid 
unspecific binding of the antibodies to the Fc receptors. After incubation for 15 min at 4 °C, 
cells were centrifuged at 400 g at room temperature for 5 min, the antibody solution was 
removed, and the cell pellet was dissolved in 400 µl PBS containing 1 % FCS (PBS/FCS). The 
cell suspension was divided for 8 different staining combinations as described in (Table 14). 
For FACS staining at least 0.2 µg of each antibody and 50 µl PBS/FCS were added to the cells 
and incubated for 30 min at 4 °C. Next the cells were centrifuged at 400 g at room 
temperature for 5 min, the supernatant was discarded, and the cells were resuspended in 
100 µl of PBS/FCS and mixed with 50 µl 4 % PFA. Acquisition of the FACS data was done using 
a LSR Fortessa (BD) and DIVA software. The data was analyzed using the FlowJo software 
Version 7.6.1. 
Table 14: Antibodies used for verification of quality and purity of the isolated T cells. 
Sample FITC PE PerCp Alexa Fluor 700 
1 - - - - 
2 CD3e  CD4  
3 CD3e CD45RB CD4  
4 CD3e - CD4 CD62L 
5 CD3e - - - 
6 - CD4 - - 
7 - - CD4 - 
8 - - - CD62L 
 
 Analysis of the murine gut microbiome using 16S metagenomics 2.2.11
2.2.11.1 Sample and metadata collection 
Mice sharing a cage were separated from each other and fresh feces was collected in a 
1.5 ml tube. The samples were stored at room temperature or on ice until frozen, or DNA 
was isolated directly from the fresh samples. 
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For each sample, the metadata listed in Table 15 were collected. Sample metadata that were 
assessed are listed. As some metadata could only be acquired post mortem, this information 
is missing for samples collected prior to sacrificing the animals. 
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Table 15: Metadata associated with assessed samples. 
Dataset Description 
Birthday Birthday of the mouse from which a sample was collected 
T-cell transfer Date of T-cell transfer.  
Histology score Sick (>1, max 3) or healthy (≤1) 
Health state end Health state of the mouse at the end of the experiment 
independent of the health state at the time of sampling 
Housing facility Animal facility in which the mouse lived (ETH or HNO) 
Sequencing run Groups of samples that were sequenced simultaneously 
Experiment number Animals of the same experiment were treated simultaneously  
Treatment Describes the treatment received by a mouse 
Organ morphology 
(MLN, spleen and 
colon) 
Information about the gross appearance of the spleen, MLN and 
colon after sacrificing the mice 
Feces texture Consistence of feces (normal, soft or diarrhea) 
Parents The breeding pair from which a mouse descended. For purchased 
animals the company is listed 
Sampling time The experimental phase in which a sample was collected 
Pool prep Information about where the sequencing library was prepared 
Gender  
Cell count MLN Classification of the number of 
viable cells extracted from the 
MLN 
 Cell count Group 
< 2 x 106 1 
Cell count cLP Classification of the number of 
viable cells extracted from the 
colonic tissue 
< 3 x 106 2 
<4 x 106 3 
>4 x 106 4 
 
At the end of an experiment the colon was removed and a short piece was used to assess 
the histology. According to the morphology a histological score was assigned. The scheme 
used for converting the morphology into a histology score was adopted from Krajina et al. 179 
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and is described in Table 16. If attributes of different scores were mixed, the score was 
accordingly adapted to be as representative as possible. Each section was scored blinded in 
three independent runs. The final score associated with a section was the mean of the three 
scorings. 
Table 17: Histological scores assigned according to observed morphological changes of colonic sections. 
Histological score Morphological features Classification 
0 
normal architecture 
no inflammatory cells 
no loss of goblet cells 
Healthy 
0.5 
few inflammatory cells 
OR 
slight reduction of goblet cells 
1 
few inflammatory cells 
AND 
slight loss of goblet cells 
Stromal edema 
1.5 
features of the histological score 1 and additionally  
severe loss of goblet cells  
OR 
intense infiltration of inflammatory cells 
Sick 
2 
Intense inflammatory infiltration 
AND 
marked reduction of goblet cells 
hyperplasia of crypts 
2.5 
features of the histological score 2 and additionally 
slight spillover of leukocytes into deeper mucosa 
OR 
complete loss of goblet cells 
OR 
distortion of mucosal architecture 
3 
spillover of leukocytes beyond mucosa into deeper layers of 
colonic wall 
AND 
complete loss of goblet cells 
AND 
Distortion of mucosal architecture, erosions or ulcerations 
and crypt abscesses 
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2.2.11.2 DNA isolation 
DNA was isolated from fecal samples using the QIAamp DNA Stool Kit (Qiagen) with a 
modified protocol.  
One dropping of mouse feces was mixed with 0.5 µl of unwashed glass beads (425-600 μm; 
Sigma) and 700 µl of ASL buffer and was mixed for 3 min at 30 Hz using a Mixer Mill MM300 
(Retsch). After centrifugation at full speed (20 814 g) for 1 min the supernatant was 
transferred into a new reagent tube. The pellet was treated with 200 µl of lysis buffer 
(20 mM Tris∙HCL, pH 8; 2 mM EDTA; 1.2 % Triton) containing 20 mg/ml lysozyme (Sigma) and 
incubated at 37 °C for 30 min to enhance the lysis of gram positive bacteria. 
Following incubation, 500 µl of ASL buffer was added. The sample was mixed using the Mixer 
Mill and incubated at 95 °C for 5 minutes. A subsequent physical lysis step, mixing the 
sample with glass beads in the Mixer Mill, increased the lysis rate of hard-to-lyse bacteria. 
The samples were then centrifuged for 1 min at full speed and the supernatant was pooled 
with that collected previously. 
To eliminate possible inhibitors of downstream applications, one halfInhibEx (Qiagen) tablet 
was added and immediately mixed with the supernatant by vortexing until the tablet 
dissolved. Inhibitors bound to the InhibEx tablet were removed by centrifugation at full 
speed for 3 min and the supernatant was transferred into a new reaction tube. By repeating 
the centrifugation step, small residues of the InhibEx tablet that were carried over could be 
removed.  
400 µl of the supernatant was mixed with 15 µl Proteinase K as well as 200 µl of AL buffer 
and incubated at 70 °C for 10 min. The volume was doubled by adding ethanol. The sample 
was briefly vortexed to ensure thorough mixing and was then transferred to a QIAamp spin 
column. After centrifugation at full speed for 1 min the filtrate was discarded and the DNA 
bound to the spin column was washed with 500 µl of washing buffer AW1. The buffer was 
removed by centrifugation at full speed for 1 min. A second wash step was performed using 
500 µl AW2 buffer and centrifugation at full speed for 3 min. To avoid the carryover of 
buffer, an additional centrifugation step (1 min at full speed) was done. 
The DNA was eluted in 100 µl heated buffer AE (70 °C) and stored at -20°C until used for 
preparing sequencing libraries.  
The purity and quality of the isolated DNA was verified by photometric analysis with a 
Nanophotometer and gel electrophoresis (Figure 12). The absorption ratios 260/280 nm and 
260/230 nm, ideally at 1.8 and between 2.0 and 2.2, respectively, were measured for the 
majority of the samples.  
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Figure 12: DNA was isolated from fecal samples using the QIAamp DNA Stool Kit (Qiagen) and a modified 
protocol. Gel electrophoresis was used for determination of degradation; purity and quantity were measured 
using a Nanophotometer. The DNA was pure and not or only slightly degraded. 
2.2.11.3 Amplicon pool preparation 
DNA isolated from fecal samples as described above was quantified using a Nanophotometer 
(Implen) and used as template in a PCR to partially amplify the bacterial 16S gene. The 
primers (M13 338F and revM13 1044R; Table 5) added to the PCR reaction bind to 
conserved segments of the 16S gene enclosing the variable regions v3-v6. The composition 
of the reaction and the amplification conditions are specified in Table 18 and Table 19.  
Table 18: PCR reagents for the amplification of 16S gene fragments 
Reagent Amount Supplier 
2x Dream Taq Master Mix 10 µl Fermentas 
M13 338F (10 µM) 1 µl biomers.net 
revM13 1044R (10 µM) 1 µl biomers.net 
DNA Template 50 ng  
Ultrapure water add to 20 µl Invitrogen 
Table 19: Thermocycler program for amplification of 16S gene fragments 
Temperature Duration 
95 °C 10 min 
95 °C 30 sec 
55 °C 30 sec 
72 °C 45 sec 
72 °C 10 min 
4 °C ∞ 
For each 5 samples one negative control was included. The result of the PCR was verified by 
visualizing the DNA product on a 1% agarose gel as described in 2.2.7 Gel electrophoresis 
(Figure 13).  
20 x 
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Figure 13: Samples were loaded onto a 1 % agarose gel and DNA was separated according to size during 
electrophoresis  at 100 V for 30 min. Successfully amplified samples were subjected to a further PCR reaction, 
provided that all negative controls showed no DNA amplification. NC= Negative control, 1-40 = Samples 
The amplicons were cleaned using the NucleoSpinExtract II Kit (Macherey-Nagel). The 
volume of each sample was adjusted to 100 µl with ultrapure water. After the addition and 
mixing of 200 µl NT Buffer the sample was loaded onto a NucleoSpin Extract II Column and 
centrifuged at 11 000 g at room temperature for 1 min. The flow-through was discarded and 
700 µl of NT3 Buffer was pipetted into the column before repeating the centrifugation. To 
ensure complete removal of any remaining buffer, the NT3 Buffer in the collection tube was 
discarded and an additional centrifugation at maximum speed for 2 min was performed, 
followed by incubation at 70 °C for 4 min with an open lid. The DNA was eluted using 15 µl of 
ultrapure water which was preheated to 70 °C, and incubated on the column for 1 min. The 
purified DNA was quantified with a NanoPhotometer. In a second PCR, a barcode sequence 
(Table 20) and an adapter sequence (Table 5) for 454-sequencing were attached to the 16S 
fragment previously amplified. The reagents and thermocycler program used for this 
reaction are described in Table 21 and Table 22.  
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Table 20: Barcode sequences attached to 16S amplicons for multiplexing  
Primer Barcode 
MID sequence 
5’→3’ 
 
Primer Barcode 
MID sequence 
5’→3’ 
MID1 ACGAGTGCGT  MID21 TGCGTGAGCA 
MID2 ACGCTCGACA  MID22 ACAGCTCGCA 
MID3 AGACGCACTC  MID23 CTCACGCAGA 
MID4 AGCACTGTAG  MID24 GATGTCACGA 
MID5 ATCAGACACG  MID25 GCACAGACTA 
MID6 ATATCGCGAG  MID26 GAGCGCTATA 
MID7 CGTGTCTCTA  MID27 ATCTCTGTGC 
MID8 CTCGCGTGTC  MID28 CTGTGCGCTC 
MID9 TAGTATCAGC  MID29 CGACTATGAT 
MID10 TCTCTATGCG  MID30 GCGTATCTCT 
MID11 TGATACGTCT  MID31 TCTGCATAGT 
MID12 TACTGAGCTA  MID32 ATCGAGTCAT 
MID13 CATAGTAGTG  MID33 GTGATGATAC 
MID14 CGAGAGATAC  MID34 CATAGAGAGC 
MID15 ATACGACGTA  MID35 ATGCAGCATA 
MID16 TCACGTACTA  MID36 ATCATGCACT 
MID17 TCGATCGAGT  MID37 TGAGCTAGCT 
MID18 CAGTCAGTAG  MID38 GATGACTGAC 
MID19 ACACTGACAC  MID39 CACAGTCACA 
MID20 GTACGATCGT  MID40 TGCTAGCATG 
Table 21: Reagents used in the PCR for attaching linker and barcode sequences. 
Reagent Amount Supplier 
Primer B_revM13 (10 µM) 1 µl Eurofins MWG Operon 
Forward primer 
(Linker+Barcode+M13 
338F) 
1 µl 
Eurofins MWG Operon 
FastStart Buffer (10x) 2.5 µl Roche 
dNTPs (2.5 mM) 2 µl Roche 
MgCl2 (25mM) 1 µl Roche 
G-C rich solution (5x) 5 µl Roche 
FastStart Taq 0.2 µl Roche 
DNA template 2-5 µl  
Ultrapure water Add up to 25 µl Invitrogen 
 
Table 22: Thermocycler program for attaching barcode and linker sequences to the 16S gene amplicons 
Temperature Duration 
95 °C 10 min 
95 °C 15 sec 
60 °C 30 sec 
72 °C 1 min 
72 °C 3 min 
4 °C ∞ 
10 x 
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The negative controls of the first reaction were continued as negative controls. Successful 
amplification of the DNA was observed by visualizing the DNA fragments using gel 
electrophoresis (1 % agarose gel). By adding several adequately diluted and randomly 
selected amplicons created during the first PCR, the increase of size and amount generated 
in the second reaction was verified (Figure 14).  
 
Figure 14: Comparing the bands of a sample after the first and second PCR shows an increase in the amount 
and length of the amplicons, indicating successful attachment of linker and barcode sequences. NC= Negative 
control, 1-40 = Samples 
In order to verify that the sequences attached to the 16S gene fragment were correct, an 
amplicon from the second PCR was randomly selected and cloned into chemically-
competent E. coli DH5α with the CloneJet PCR Cloning Kit (Fermentas; described in 2.2.11.4) 
and sent to GATC (Konstanz) for Sanger sequencing. 
The labeled 16S amplicons originating from different samples were pooled. Different 
amplification efficiencies were compensated for by increasing or decreasing the amount of 
DNA added to the pool before purification of the amplicon mixture. The volume of the 
sample pool was adjusted to at least 400 µl with ultrapure water (Invitrogen) and increased 
by 1/10 with 3 M sodium acetate and subsequently by 2.5 fold of the pool volume with 
ethanol (Merck). After the ingredients were thoroughly mixed, the sample was centrifuged 
at 4 °C and 20,000 g for 30 min. The supernatant was discarded, 500 µl of 70 % ethanol was 
added to the pellet and the sample was centrifuged for 15 min at 4 °C at 20,000 g. After 
removing the supernatant the DNA pellet was air dried and resuspended in 50 µl of 
ultrapure water. Amplicons were size-separated by electrophoresis on a 1 % agarose gel 
(Figure 15). The band at 750 bp was excised from the gel and purified using the 
NucleoSpinExtract II Kit (Macherey-Nagel) according to manufacturer’s instructions. The DNA 
was eluted in 20 µl of ultrapure water which was preheated to 70 °C. The DNA concentration 
of the amplicon pool was determined using a nano photometer (2.2.8.1 NanoPhotometer 
(Implen)) and sent to Eurofins MWG Operon for sequencing on a GS FLX (Roche). A 
maximum of 20 or 40 samples were sequenced on quarter and half of a GS FLX sequencing 
 Materials and Methods 
 
40 
plate, respectively. The amplicon pool was kept at 4 °C for short term storage and shipping 
to Eurofins MWG operon. 
 
Figure 15: Amplicon pools were purified by electrophoresis and subsequently recovered from the agarose gel 
2.2.11.4 Verifying the attachment of the linker and barcode sequences 
Prior to 16S amplicon sequencing, it was verified that the appropriate linker and barcode 
sequence attachment to the 16S gene amplicon, using the CloneJet PCR Cloning Kit 
(Fermentas). 
In the first reaction, the sticky ends of a PCR product were removed in a blunting reaction 
containing 10 µl of 2x Reaction buffer, 1-2 µl unpurified PCR product, 1 µl DNA blunting 
enzyme and water to a total volume of 18 µl. The reaction mix was briefly vortexed and 
centrifuged before incubation at 70 °C for 5 min followed by a quick chill on ice. Next, 1 µl of 
pJet1.2/blunt Cloning Vector (50 ng/µl) and 1 µl T4 DNA ligase were added, briefly mixed, 
and centrifuged. The ligation of the PCR product to the vector took place during incubation 
at room temperature for 5 min. This mixture was used for bacterial transformation. 200 µl of 
chemically-competent E. coli DH5 were thawed on ice before mixing with 5 µl of the 
ligation product and incubation on ice for 30 min. The bacterial cells were heat shocked at 
37 °C for 45 sec and immediately returned to ice for 2 min. The bacteria were grown in 800 
µl LB-media at 37 °C and 650 rpm for 1 hour. For selection of the transformed bacteria, 
bacteria were plated onto a LB-plate containing 100 µg/ml ampicillin and grown over night 
at 37 °C. One colony was selected and used to inoculate 3 ml of liquid LB-media containing 
100 µg/ml ampicillin. After incubation for 4 h at 37 °C and 200 rpm the plasmid was isolated 
using the NucleoSpin Plasmid Kit (Macherey Nagel). Bacteria were separated from the media 
by centrifugation for 5 min at 4,000 g and media was discarded. For cell lysis, 250 µl each of 
Buffers A1 and A2 were added, followed by incubation at room temperature for 5 min, and 
the addition of 300 µl Buffer A3. The lysate was separated from particles by centrifugation at 
11,000 g for 5 min and subsequently transferred to a NucleoSpin Plasmid Column. After 
centrifugation at 11 000 g for 1 min, the flow-through was discarded and the DNA bound to 
the silica membrane was washed, first with 500 µl AW Buffer preheated to 50 °C, then with 
600 µl Buffer A4. The buffers were removed by centrifugation at 11,000 g for 1 min. Flow-
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through was discarded and an additional centrifugation for 2 min at 11,000 g ensured 
complete removal of buffer residues. DNA was eluted by applying 50 µl of ultrapure water 
(preheated to 70 °C) to the column for 1 min at room temperature and recaptured by 
centrifugation for 1 min at 11,000 g.  
Amplification of the PCR fragment and the flanking regions of the cloning vector after 
successful ligation results in an amplicon with a length of approximately 1,000 bp (Figure 
16). The reagents used in the PCR reaction are listed in Table 23 
 
Figure 16: Electrophoresis confirms that the isolated pJet 1.2/blunt cloning vector and the incorporated PCR 
fragment is 1000 bp in length. 
 
Table 23: Reagents for amplification of the PCR product integrated into the pJet1.2/blunt Cloning Vector 
Reagents Volume Supplier 
10 x Taq buffer with MgCL2 2 µl Fermentas 
dNTP mix (2.5 mM) 2 µl Fermentas 
pJET 1.2 forward sequencing 
primer (10 µM) 
0.4 µl Fermentas 
pJET 1.2 reverse sequencing 
primer (10 µM) 
0.4 µl Fermentas 
Taq DNA polymerase (5u/µl) 0.1 µl Fermentas 
Ultrapure water 15.1 µl Invitrogen 
Sequencing data was analyzed to determine whether the barcode and linker sequences were 
complete and connected to the 16S rDNA amplicon in the correct manner. Figure 17 shows 
the sequence received after Sanger sequencing. The linker, barcode and universal primer 
binding site of the 16S rRNA gene are highlighted. 
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Figure 17: Attachment of linker and barcode sequences was confirmed by Sanger sequencing. Linker 
sequence Lib-A and barcode sequence are colored in blue and green, the universal binding site for the 
forward primer in gray. The universal binding site for the reverse primer and the linker sequence Lib-B are 
colored in light and dark red, respectively. 
 
2.2.11.5 Sequencing 
The purified amplicon pool was quantified using a NanoPhotometer (Implen) and sent to 
Eurofins MWG Operon (Ebersberg) for 454-sequencing on a GS FLX (Roche) with the 
Titanium series chemistry. Eurofins MWG Operon prepared the sequencing library from the 
sample pool. A pool of up to 20 Samples was sequenced on quarter segment of a full GS FLX 
run, and a pool of up to 40 samples was run on half segment.  
 Analysis of the murine gut metagenome using shotgun metagenomics 2.2.12
2.2.12.1 Sampling 
Fecal samples were collected from the individual mice and immediately stored on ice until 
frozen at -80 °C. Samples were then randomized to minimize technical differences between 
groups. Samples were collected on the day of T-cell transfer as well as 4, 6 and for some 
groups, 8 weeks after T-cell transfer. 
2.2.12.2 DNA isolation 
DNA was isolated from one mouse dropping. 250 µl of Guanidine Thiocyanate and 40 µl of 
10 % N-Lauryl sarcosine were added to the frozen fecal sample. the fecal sample was left at 
room temperature for 10 min to ensure complete thaw before 500 µl of 5 % N-Lauryl 
sarcosine was added. The feces was subsequently scattered using an inoculation loop, the 
solution was homogenized by vortexing and then shortly spun down in the centrifuge and 
incubated at 70 °C for 1 hour. 
After incubation, 750 µl of unwashed glass beads (425-600 μm; Sigma) was added. The 
sample was homogenized through shaking on a horizontal vortexer for 10 min (Vortex Genie 
2 (Scientific Industries) speed: 6). 15 mg of polyvinylpyrrolidone (PVPP) was added and the 
sample was vortexed until the PVPP was no longer at the surface, after which it was 
centrifuged at 20,814 g for 3 min. 
CATTGAATGTATTCTTAGAGCAATTCTAAACAATTGGGGTCCGGCCACGTCCGAAAGTGCACCTACTCTAGAACCAATTA 
TTCCATGACTTAACTTAAATAGCGTACACGAGCCGCCCTGCAGCGATAATTATTTGCAATAATTTTAACAAAAGCTCTAA 
GTCCTCTCATTAATTCTAGATGATACTTCATCTGGAAATGTCCCATAGTAGCATCACGCTGTGAGTAAGTCTAAACCATT 
TTTTATGTGTATATCTCTAATCTACTACTCGATGAGTTTTCGGTATATCTCTATTTTTAACTTGGAGCAGGTTCCATTCA 
TTGTTTTTTCATCATAGTGAATAAAATCAACTGCTTTAACACTTGTGCCTGAACACCATATCCATCCGGCGTAATACGAC 
TCACTATAGGGAGAGCGGCCGCCAGATCTTCCGGATGGCTCGAGTTTTTCAGCAAGATCGTATCGCCTCCCTCGCGCCAT 
CAGCACAGTCACAGTAAACGACGGCCAGTGCTCCTACGGGTGGCAGCAGTGAGGAATATTGGTCAATGGCCGAGAGGCTG 
AACCAGCCAAGTCGCGTGAGGGAAGACGGCCCTACGGGTTGTAAACCTCTTTTGTCAGGGAGCAAAGAACGTCACGTGTG 
GCGTCTCGAGAGTACCTGAAGAAAAAGCATCGGCTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGATGCGAGCGTTA 
TCCGGATTTATTGGGTTTAAAGGGTGCGCAGGCGGGATGCCAAGTCAGCGGTCAAATTTCGGGGCTCAACCCCGACCTGC 
CGTTGAAACTGGTGTCCTAGAGTGGGCGAGAAGTATGCGGAATGCGTGGTGTAGCGGTGAAATGCATAGATATCACGCAG 
AACTCCGATTGCGAAGGCAGCATACCGGCGCCCAACTGACGCTCATGCACGAAAGCGTGGGTATCGAACAGGATTAGATA 
CCCTGGTAGTCCACGCAGTAAACGATGAATACTAACTGTCCGGTCCGAATGAGGACTGGGTGGTACAGCGAAAGCGTTAA 
GTATTCCACCTGGGGAGTACGCCGGCAACGGTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGAGGAACATGTG 
GTTTAATTCGATGATACGCGAGGAACCTTACCCGGGCTCAAACGACACAGGAATACTTTTGAAAGGAGGTAGCTCTACGG 
AGCCTGTGTCGAGGTGCTGCATGGCTGTCGTCAGCTCGTAGTCATGGTCATAGCTGTTTCCCTGAGCGGGCTGGCAAGGC 
GCATAGATCTTCTAGAAGATCTCGACAAATGACGG 
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The supernatant was transferred into a new tube and stored on ice, while the pellet was 
washed with 500 µl TENP (Tris, EDTA, NaCl and PVPP). The resuspended pellet was again 
centrifuged at 20,814 g for 3 min and the supernatants were pooled. The washing was 
repeated to a total amount of 3 washes. The pooled supernatants were centrifuged at 
20,814 g for 3 min to minimize carryover of contaminants. After centrifugation the 
supernatant was distributed into two new tubes. 1 ml isopropanol (Merck) was added to 
each portion of the supernatant and mixed by inverting the tubes. This mixture was 
incubated at room temperature for 10 min and centrifuged at 20,814 g for 10 min. 
Supernatant was discarded and the pellet was air-dried under the fume hood for 10 min. 
The dried pellet was dissolved in 450 µl Phosphate buffer and 50 µl Potassium Acetate by 
pipetting up and down. The two samples were pooled, incubated on ice for 90 min and 
centrifuged at 4 °C for 35 min. The supernatant was transferred into a new tube and 2 µl of 
RNase (10 mg/ml) were added and mixed into the sample by vortexing. Following a brief 
centrifugation the sample was incubated at 37 °C for 30 min. 50 µl of Sodium-acetate and 1 
ml of ice cold ethanol (Merck) were added and the sample was mixed by inverting the tube 
several times and incubated at room temperature for 5 min. The ethanol was removed by 
centrifuging the sample for 5 min at 20,814 g and aspiration of the supernatant. The pellet 
was washed with ice cold 70 % ethanol and centrifuged at 20,814 g for 5 min. The ethanol 
was removed and the wash was repeated with 500 µl 70 % ethanol. The DNA pellet was 
dried at 37 °C for 15 min and resuspended in 100 µl TE Buffer. The DNA was incubated at 4 
°C overnight and homogenized by pipetting up and down a several times 180,181. 
DNA concentration was assessed as described in 2.2.8.2.2 Measurement with the Qubit2.0. 
The average DNA yield per sample was approximately 100 ng/µl. Samples were stored at -20 
°C until Illumina sequencing. 
Agarose gel electrophoresis was used to verify that extracted DNA was not degraded (Figure 
18). 
 
Figure 18: DNA isolated for metagenomic analysis showed no signs of degradation. 
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Table 24: Buffers for DNA isolation for metagenomics 
Buffer Contents 
Na2HPO4 (1M) 
8.9 g Na2HPO4 (Merck)  
50 ml H2O 
NaH2PO4 (1M) 
6.9 g NaH2PO4 (Applichem) 
50 ml H2O 
EDTA, 2 H2O 
(0.5 M) 
pH 8 
 
9.305 g EDTA (AMRESCO) 
50 ml of H2O 
Dissolve by heating 
Adjust to pH 8 using NaOH 
Tris-HCl (1 M ) 
pH 7.5 and pH 8 
6.05 g Tris (Applichem) 
50 ml H2O 
Adjust to pH 7.5 and pH 8 with HCl 
NaCl (5 M) 
14.6 g NaCl (VWR Chemicals) 
50 ml H2O 
N-lauroyl sarcosine 
(10%) 
2 g N-lauroyl sarcosine (Sigma) 
20 ml H2O 
N-lauroyl sarcosine 
(5%) 
1 g N-lauroyl sarcosine (Sigma) 
20 ml phosphate buffer (0.1 M, pH 8) 
Potassium acetate 
(5 M acetate, 3 M 
potassium) 
29.44 g potassium acetate (Merck) 
11.5 ml glacial acetic acid (Merck) 
28.5 ml H2O 
Adjust to 100 ml with H2O 
Sodium acetate 
(3 M) 
 
12.304 g Sodium acetate (Merck) 
40 ml H2O 
Adjust to pH 5.2 with glacial acetic acid 
Adjust to 50 ml with H2O 
Ethanol (70%) 
70 ml ethanol (Merck) 
30 ml H2O 
Phosphate buffer 
(0.1 M) 
pH 8 
9,32 mL Na2HPO4 (1M) 
0,68 ml NaH2PO4 (1M)  
90 ml H2O  
Adjust to pH 8 
TENP (50 M Tris, 20 
mM EDTA, 100 mM 
NaCl, 1 % PVPP) 
1.5 ml Tris (1 M, pH 8) 
1.2 ml EDTA (0.5 M, pH 8) 
0.6 ml NaCl (5 M) 
0.3 g PVPP (polyvinylpyrrolidone K90,Flucka 81438) NB: will not be 
dissolved 
Adjust to a total of 30 ml with H2O 
Guanidine 
Thiocyanate (4 M) 
12.37 g guanidine thiocyanate (work in the fumehood) (Applichem) 
13.5 ml H2O 
2.6 ml Tris (1 M, pH 7.5) 
Agitate overnight in the dark 
Add 26.1 ml H2O 
TE buffer (10 mM 
Tris, 1 M, 1 mM 
EDTA)pH 8 
200 µl Tris, 1 M, pH 8 
40 µl EDTA 0.5 M, pH 8 
20 ml H2O 
RNase 
(Ribonuclease, 
Sigma R6513), 
10 mg/ml: 
200 µl RNase (100 mg/ml Qiagen) 
20 µl Tris, 1 M, pH 7.5 
6 µl NaCl, 5 M 
Adjust to 2 ml with H2O 
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 Analysis of the gut transcriptome of gnotobiotic mice 2.2.13
2.2.13.1 Sampling 
Germfree C57Bl/6 mice were colonized with either B. vulgatus mpk, E. coli mpk, or both 
bacterial strains, administered for 10 days via the drinking water. Fecal samples were 
collected after colonization, suspended in 1 ml RNAprotect Bacteria Reagent (Qiagen) and 
frozen at -80 °C. 
2.2.13.2 RNA isolation 
The ZR Soil/Fecal RNA MicroPrep (Zymo Research) kit was used to isolate RNA from fecal 
samples. Before starting with the RNA isolation, the Zymo-Spin IV-HRC Spin Filter was 
prepared as described by the manufacturer by centrifugation at 8,000 g for 3 min.  
Fecal samples stored at -80 °C in RNAprotect Bacteria Reagent (Qiagen) were thawed and 
centrifuged at 4 000 g for 5 min. The RNAprotect Bacteria Reagent was removed, the fecal 
sample was transferred into the ZR BashingBead Lysis Tube, and 900 µl of S/F RNA Lysis 
Buffer was added. The sample was mixed on a horizontal vortexer for 3 min at full speed and 
subsequently centrifuged for 1 min at 12,000 g. 400 µl of the supernatant was transferred to 
a new tube, mixed with the same volume of RNA Binding Buffer, pipetted onto a Zymo-Spin 
IIIC Column and centrifuged at 12,000g for 30 sec. The volume of the flow-through was 
doubled using ethanol (Merck) and mixed thoroughly. Half of the sample was transferred 
onto a new Zymo-Spin IIIC Column and centrifuged at 12,000g for 30 sec. This step was 
repeated with the remaining sample. The RNA was washed by loading the column with 400 
µl RNA Prep Buffer and centrifugation at 12,000g for 1 min and then eluted by incubating 
100 µl of DNase/RNase-Free Water for 1 min at room temperature on the matrix of the 
column. RNA was collected by centrifugation at 12,000 g for 30 sec, then further cleaned by 
passing it through a prepared Zymo-Spin IV-HRC Spin Filter via centrifugation for 1 min at 
8,000 g. 
DNA contamination was removed by adding 10 µl of 10x DNase I Buffer (Ambion, DNA-free 
Kit), 2 µl rRNasin (Promega) and 4 µl rDNase I (Ambion, DNA-free Kit) to the sample 
followedby incubation at room temperature for 30 min. The DNA digestion was terminated 
by adding 12 µl of DNase Inactivation Reagent (Ambion, DNA-free Kit) and incubated for 2 
min at room temperature. During this time the sample was regularly mixed on a shaker, then 
centrifuged for 1 min at room temperature at 10,000 g and the supernatant then transferred 
into a new reaction tube. 
The volume of the RNA sample after DNase treatment was increased by adding twice as 
much RNA Binding Buffer and mixing the ingredients well by pipetting up and down. The 
new volume was doubled by adding ethanol, then homogenized and transferred onto a 
Zymo-Spin IC Column. After centrifugation at 12,000 g for 1 min the flow-through was 
removed and the column washed by the addition of 400 µl RNA Prep Buffer and 
centrifugation at 12,000 g for 1 min. Two more washes followed, first with 700 µl then 400 µl 
RNA Wash Buffer and centrifugation at 12,000 g for 30 sec. Transfer to a new collection tube 
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followed by centrifugation at 12,000 g for 2 min ensured the complete removal of any 
remaining buffer. The RNA was eluted from the column by incubating 10 µl of DNase/RNase 
Free Water on the matrix of the spin column for 1 min at room temperature and 
centrifugation at full speed for 30 sec. 
For quality control and quantification, 1 µl of the sample was run on an Agilent Bioanalyzer 
2100 using the RNA 6000 Nano Kit. 
 Statistics 2.2.14
Statistical analyses were performed using the unpaired Student’s t-Test to compare two 
groups. Results were considered statistically significant if p < 0.05, indicated by *. Error bars 
represent ± SEM. 
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3. Results 
3.1 Fluorescence in situ hybridization (FISH) 
 Establishing a hybridization protocol 3.1.1
The protocol used for fluorescence in situ hybridization (FISH) was established using fresh or 
PFA fixed (2.2.3.1 Sample fixation) bacteria, before applying it to fecal samples. The signals 
detected were generally stronger if the bacteria were PFA fixed prior to FISH. Multiple 
variations of the approach described in 2.2.3 Fluorescence in Situ Hybridization (FISH) were 
tested.  
3.1.1.1 Formamide concentration 
Formamide reduces the melting point of double stranded nucleic acids, thus reducing the 
annealing temperature and consequently the temperature needed for hybridization 182. 
Lower incubation temperatures better preserve cell morphology; however, formamide is 
toxic, so the minimal effective amount should be used. Two concentrations (20 % and 30 %) 
were tested.  
No difference between 30% vs. 20% formamide was found in the E. coli sample. Probe 
hybridization to B. vulgatus was barely detectable at the higher concentration, and only 
became visible after strong enhancement of the signal. For these reasons, the lower 
concentration was chosen for further experiments. 
3.1.1.2 Duration of hybridization 
Variations of the hybridization time (between 1 and 18 h) showed that longer hybridization 
didn’t generally improve the labeling of bacteria; in contrast, the Fluorescin and Cy5 dyes 
seemed to fade faster and signals of the Fluorescin were only visible after strong artificial 
enhancement. After incubation for 2 h 45 min the hybridization results were comparable to 
those after 18 h incubation. Figure 19 and Figure 20 show E. coli and B. vulgatus hybridized 
with the Eub, Ent or Bac probes after 1 h (F-H), 2.75 h (I-L) and 18 h (M-P) incubation.  
3.1.1.3 Pre-hybridization 
The necessity of a pre-hybridization step was investigated by covering samples with 
hybridization buffer and incubating them at 46 °C for about 40 min prior to hybridization. 
The efficiencies with and without pre-hybridization were comparable, demonstrating that 
the additional step was unnecessary. 
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Figure 19: Fluorescent in situ hybridization (FISH) of E. coli with an eubacterial, an enterobacterial probe and one specific for B. vulgatus with different hybridization 
conditions. The best results were achieved using 20 % Formamide and hybridizing the probe for 1 h; therefore, these conditions were used in all following experiments. 
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Figure 20: Fluorescent in situ hybridization (FISH) of  B. vulgatus with an eubacterial, an enterobacterial probe and one specific for B. vulgatus with different hybridization 
conditions. The best results were achieved using 20 % Formamide and hybridizing the probe for 1 h; therefore, these conditions were used in all following experiments.
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 Selection of appropriate probes  3.1.2
The specificity of the FISH probes used for labeling was appraised by in silico comparison of 
the probe sequences with known bacterial genome sequences, and by experimentally 
testing if bacteria other than those predicted were recognized by the probes.  
Different bacterial species were selected to confirm the probe specificity. Probes with 
sequences specific for eubacteria, Enterobacteria, Bacteroidetes or Bacteroides vulgatus 
were selected and labeled with Cy5, Cy3, Fluorescin or Alexa Fluor 488. DNA was also stained 
using DAPI. PFA fixed microbes were hybridized with the probes and visualized using a Leica 
DMRE microscope with a 100 fold magnification.  
Table 25 summarizes which bacterial species were targeted by the selected probes. With the 
exception of Staphylococci, all bacteria could be stained using the Eubacterial (Eub) probe. 
Only Enterobacteria (Ent) were marked by that specific probe and the Bacteriodetes (Bac) 
probe hybridized with all bacterial strains belonging to this genus whereas the B. vulgatus 
specific probe did not bind to other Bacteroides.  
Table 25: The probes to detect eubacteria, Enterobacteria, Bacteroidetes and B. vulgatus were tested with PFA 
fixated bacteria to confirm specificity.  indicates successful hybridization whereas  indicates that no 
fluorescence could be detected. 
Probe 
Bacteria 
Eub Ent Bac B.v. 
B. vulgatus    
B. dorei    
B. fragilis    
B. thetaiotaomicron    
E. cloacae    
E. coli    
E. durans    
E. faecalis    
E. gallinarum    
K. pneumoniae    
P. aeruginosa    
S. aureus    
S. epidermidis    
S. pneumonia    
 From single to multiple staining 3.1.3
Simultaneous staining of different bacteria within one sample can drastically reduce the time 
and material needed. The possible combinations of different probes depend on the 
fluorescent labels and the ability to detect the probes separately; experimental fluorescent 
dyes were chosen accordingly. The extinction and emission wavelengths of the chosen dyes 
listed in Table 15 were theoretically far enough apart for differential detection when using 
appropriate filters.  
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Table 26: Fluorescent dyes attached to probes for specific labeling of bacteria. Information was retrieved 
from the Eurofins MWG Operon (www.eurofinsgenomics.eu) and Olympus (http://www.olympusmicro.com) 
websites 
Flourescent dye 
Extinction 
wavelength 
Emission 
wavelength 
Color of 
fluorescence 
Fluorescin 495 nm 520 nm Green 
Cy 5 647 nm 673 nm Red 
Cy 3 550 nm 568 nm Orange 
Alexa Fluor 488 495 nm 519 nm Green 
DAPI 350 nm 470 nm  Blue  
The filters used with the Leica DMRE for selectively visualizing different dyes are listed in 
Table 8. Individual Cy3 stained bacteria, however, were also visible through the filter used 
for the Fluorescin and Alexa Fluor 488 staining. Even though Cy3 fluorescence was not 
eliminated by this filter, the different bacteria could be distinguished because Cy3 appeared 
yellow instead of the green specific for Fluorescin and Alexa Fluor 488. The camera used for 
documentation, however, only detects light intensities, not colors. The signal of the Cy3 dye 
detected through the filter for green fluorescence was too high to correctly identify the 
fluorescent dye responsible for the signal, and compensation for intensities was not 
successful. Cy3 stained bacteria therefore appeared to be stained with Fluorescin or Alexa 
Fluor 488 (Figure 21). 
 
Figure 21: Cy3 labeled bacteria are detected through the filter used for Fluorescin and Alexa Fluor 488. 
A mixture of the bacteria listed in Table 25 was stained with the Eubacterial probe (Cy5), the 
Enterobacterial probe (Cy3) and the Bacteroidetes probe (Alexa Fluor 488). Figure 22 shows 
the single detection channels (A-D) and overlays (E and F). Bacteria stained with Cy3 were 
also detected by the filter for Alexa Fluor 488, and therefore appear yellow in the overlay (E). 
Bacteria selectively stained by Alexa Fluor 488 appear green. The overlay (E) shows that the 
majority of the DAPI stained bacteria were also colored by the Enterobacterial or 
Bacteriodetes probes. Only DAPI stained bacteria are highlighted by white circles. The 
coloring with the Eubacterial probe did not vary from DAPI staining (F).  
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Figure 22: Fluorescent in situ hybridization of a bacterial mixture. The Eubacterial probe (Cy5) colors all 
bacteria (A) as does the DAPI staining (B). The Enterobacterial probe (Cy5) (C) and the Bacteroidetes probe 
(Alexa Fluor 488) (D) selectively hybridized with the respective bacteria. An overlay of the Alexa Fluor 488, 
Cy3 and DAPI staining (E) enables differentiation of bacteria according to coloring. F shows that all DAPI 
stained bacteria were recognized by the Eubacterial probe. 
Changing the microscope used for visualizing the fluorescently dyed bacteria solved this 
problem. With the confocal scanning microscope LSM 710 NLO (Zeiss) the colors could be 
differentiated, permitting simultaneous staining and visualization with Cy3, Cy5 and Alexa 
Fluor 488. 
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3.2 T-cell isolation 
Use of the Rag1-/- T-cell transfer model required the isolation of naïve CD4+ T-cells from the 
spleen of C57Bl/6 mice. Before transferring them to Rag1-/- mice, the purity of the T-cells 
was confirmed by FACS analysis. T-cells were stained for the surface markers CD3, CD4, 
CD45RB and CD62L (L-selectin). T-cells used for the induction of colitis in Rag1-/- animals 
showed CD62L expression of 78.96% ± 1.69% and CD45RBhi expression of 66,68 % ± 4,59 % 
(Figure 23). The majority of T-cells were therefore considered naïve. 
 
Figure 23: Purity of the isolated naïve T-cells was confirmed by staining for surface markers CD3, CD4, 
CD45RB and CD62L 
The T-cells transferred into Rag1-/- mice could be recovered from the colonic Lamina Propria 
(cLP) and the Mesenteric Lymph Node (MLN) 6-8 weeks after T-cell transfer and analyzed by 
FACS (Figure 24 A). In cases where recovery failed, as shown in Figure 24 B, the mice were 
excluded from the evaluation. 
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Figure 24: After successful T-cell transfer, T-cells can be isolated from the colonic Lampina Propria. FACS 
analysis after (A) successful and (B) ineffective T-cell transfer. 
3.3 Comparability of individual 454-Sequencing runs 
One sequencing run delivers a limited number of reads. If samples are pooled, the reads are 
divided among these samples resulting in a reduction of the coverage of each individual 
sample. To ensure sufficient coverage, samples must be split into multiple sequencing runs. 
The comparability of these runs is assessed by including a control sample. The DNA for this 
sample was isolated from cultivated bacteria and pooled in an equimolar manner (900 ng 
per sample). The components of the control are listed in Table 27. Figure 25 shows the 
16S amplicon sequencing data of 3 sequencing runs of the control sample on different 
taxonomic levels, all showing slight differences between the runs. Associations of reads to 
taxa that were not included in the control sample were seen at the family level and below. 
These false families were, however, only represented by a maximum of 0.06 % of the reads. 
The family Peptostreptococcaceae, represented by C. difficile, was not detected in two of the 
three controls.  
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Table 27: Components of the control sample for 454-sequencing of 16S amplicons. DNA concentrations were 
measured using the QuantIT HS kit (Invitrogen) 
Bacteria DNA concentration 
B. fragilis 276.04 ng/µl 
B. subtilis 273.75 ng/µl 
B. thetaiotaomicron 330.74 ng/µl 
B. vulgatus 279.16 ng/µl 
C. difficile 22.85 ng/µl 
E. cloacae 293.85 ng/µl 
E. coli JM83 286.02 ng/µl 
E. durans 40.14 ng/µl 
E. faecalis 33.95 ng/µl 
E. gallinarum 38.80 ng/µl 
K. pneumoniae 275.90 ng/µl 
L. casei 10.71 ng/µl 
P. aeruginosa 288.35 ng/µl 
P. bivia 243.25 ng/µl 
S. aureus 67.44 ng/µl 
S. epidermidis 29.21 ng/µl 
S. pneumonia 202.37 ng/µl 
S. thermophilus 163.69 ng/µl 
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Figure 25: The same positive control was analyzed in three independent sequencing runs and compared to 
the actual added amounts of bacteria. Only slight variations concerning the amounts of the reads belonging to 
the different bacterial groups were seen.  
3.4 The intestinal microbiome in homoeostasis and inflammation 
For analyzing the intestinal microbiome and its influence on maintaining homoeostasis or 
development of IBD the Rag1-/- T-cell transfer mouse model was used. Genetically identical 
mice were colonized with two different microbiotas. The Endolo mice were previously shown 
to harbor a low endotoxic microbiota and maintain homoeostasis after T-cell reconstitution, 
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whereas the Endohi mice are colonized with a high endotoxic microbiota and develop colitis 
6-8 weeks after transfer of CD4+ T-cells 183. The goal was to analyze which components of the 
microbiota favor IBD development and which components are responsible for maintenance 
of homeostasis. Rag1-/- mice cannot develop an adaptive immune response because the 
development of mature B and T-cells is impaired. Prior to T-cell transfer, the intestinal 
microbiota of these mice is therefore not influenced by gut inflammation. After the transfer 
of naïve T-cells, changes of the intestinal microbiota can be associated to IBD development, 
and comparing the microbiota of mice with and without manifested IBD can give insight into 
the influence of inflammation on the composition of the gut microbiota. 
The following experimental setup was used to distinguish between the influence of the 
microbiota on the development of IBD and vice versa, the impact of inflammation on the 
microbiota: 
Endolo and Endohi mice were transferred with naïve CD4+ T-cells on day 0 after collection of a 
fecal sample. Further fecal samples were collected over a timeframe of 6-8 weeks (Figure 
26). During this time the Endolo mice stayed healthy whereas the Endohi mice developed 
colitis. The microbiota of Endolo mice and Endohi mice prior to T-cell transfer were compared 
to identify potential components responsible for predisposition to colitis. In week three the 
animals did not yet show signs of illness such as diarrhea or a relieving posture, however, the 
immune reaction has started. Samples were collected at this time to give indication as to 
which components of the intestinal microbiota were affected by the immune reaction and 
might even act as drivers of inflammation. Samples collected from Endolo mice in week 3 
showed the effect the transfer of T-cells had on the intestinal microbiota without the 
additional impact of inflammation.  
 
Figure 26: Experimental setup for identification of microbiota components predisposing mice to colitis, and 
changes during disease development and microbiota during inflammation. Endolo and Endohi mice were 
treated with antibiotics for 3 days and subsequently transferred with 5 x 105 naïve CD4+ T-cells after 
collection of a fecal sample. Further fecal samples were collected 3 and 6 weeks after T-cell transfer. Endolo 
mice stayed healthy (green) after T-cell transfer, whereas Endohi mice developed colitis (red). 
All fecal samples were collected and frozen at -80 °C as soon as possible until DNA was 
isolated and sequenced.  
The raw sequencing data was filtered for quality, sorted according to the barcode sequences 
and analyzed using Qiime 178 by Hans-Joachim Ruscheweyh, from the Department for 
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Algorithms in Bioinformatics, Tübingen. The data was visualized using Emperor 184 and 
Megan5 173. 
The similarity of the composition of the gut microbiome of different mice can be analyzed 
using principal coordinates analysis (PCoA). The distances between the samples within the 
resulting dot plots represent their similarity. The greater the difference of the intestinal 
microbiome, the further apart the samples are located on the plot.  
Distances among the samples, estimated by PCoA, were visualized using the Emperor 
software or Megan. For calculating distances between the samples, Emperor uses a 
phylogenetic tree created by dividing the sequencing reads into operational taxonomic units 
(OTUs). The reads within one OTU are at least 97 % identical. In contrast, the basis of the 
analysis with Megan is a phylogenetic tree created after association of the sequencing reads 
to different taxonomic groups. Association of a read to the lowest (genus) possible, but 
highest (kingdom) necessary, taxa minimizes false correlations. For example if a read maps 
to two genera with similar identity it will be linked to the lowest common taxa e.g. family 
instead.  
Emperor is an interactive viewer depicting the PCoA results as 3D plots whereas Megan uses 
a 2D image. In the first case the three components explaining the highest variances are 
considered whereas in the latter only the two most prominent components influence the 
graph. The unweighted unifrac method was used in both cases to calculate the distances 
between samples creating the distance matrices needed for PCoA. 
 Microbiota differs between mice resistant or prone to disease 3.4.1
The initial microbiota (= microbiome present when T-cells are transferred) of the Rag1-/- 
mice is represented by the animal facility in which they were housed (Endolo = HNO, 
Endohi = ETH). The differences between the starting microbiomes was analyzed first. 
Irrespective of treatment, time elapsed between T-cell transfer and sampling, health state or 
other metadata, the principal component analysis shows that samples that accumulate 
within one region mainly originate from Endohi or Endolo mice (Figure 27). Notably, not all 
samples from the same animal housing facility cluster, although a general separation 
between the samples collected in the other animal facility is apparent, indicating that 
environmental factors of the housing facilities impacts the microbiota more strongly than 
other metadata, and even treatment prior to day 0 (Figure 27). The PCoA computed using 
Megan, however, does not show the same subdivisions (Figure 27) or divisions correlating 
with other metadata. 
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As the immune system and the intestinal microbiome are known to influence each other, it 
was expected that after T-cell transfer, changes of the microbiome would become apparent, 
especially in mice that develop colitis. To analyze differences of the initial microbiota of 
Endohi and Endolo animals, samples from week 3 and 6 were eliminated from the plot, 
Figure 27: Principal Coordinates Analysis of intestinal microbiota of Endohi and Endolo mice in week 0, 3 or 6. 
Each dot represents one sample. Coloring depends upon the housing facility of the specific mouse. Red dots 
represent Endohi mice and blue data points Endolo mice. The same PCoA is depicted twice from two different 
angles. All samples analyzed are included, irrespective of metadata other than sampling time. Percentages 
associated with the axes quantify the variances explained by the corresponding principal component. The left  
graphs were created with Megan, the right graphs were made using Emperor. 
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resulting in a more evident separation of the Endohi and Endolo animals. The clustering of 
Endohi and Endolo mice prior to T-cell transfer was evident in the PCoA visualized using 
Emperor (Figure 28) as well as that created using Megan (Figure 29). In addition, both plots 
show that the Endohi (red, ETH) animals were divided into two clusters, both of which were 
separated from the Endolo (blue, HNO) cluster. 
 
Figure 28: PCoA, visualized using Emperor, of all samples collected in week 0 without selection due to 
metadata. The samples are colored according to the animal housing facility of the mice. The same plot is 
shown from two different perspectives. 
 
Figure 29: PCoA analysis of all samples collected on the day of T-cell transfer, created using Megan. No pre-
selection occurred. Coloring represents the animal facility in which the mouse was housed. Red indicates 
samples collected in "ETH", blue in "HNO". 
 
 Contribution of different metadata to clustering of datasets 3.4.2
Metadata such as the treatment of a mouse, its age, and health state at the end of an 
experiment or at the time of sampling were collected for every sample analyzed. If one of 
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these properties severely influenced the composition of the intestinal microbiome, it would 
be expected that all samples of the same group sharing that property cluster. It could, for 
example, be assumed that all mice with manifested inflammation harbor similar bacteria 
that differ from those present in healthy mice. The major factor influencing dataset 
clustering was correlated with the facility in which mice in an experiment were housed 
(Figure 28). This correlation was even obvious when including all the sequenced samples, 
irrespective of any other metadata or treatment and when comparing samples collected 
prior to T-cell Transfer. The only other Metadata that seemed to be responsible for 
clustering of datasets, was the experiment an animal was included into (Figure 30). Principal 
Coordinate Analysis visualized by Emperor and Megan showed the same results.  
 
Figure 30: PCoA of all samples (Endohi and Endolo) independent of any metadata (A) and all samples collected 
before T-cell reconstitution (B). The data points are colored according to the experiments in which a mouse 
was included. The figure was created using Emperor. 
To avoid that environmental influences impact the results to an extent that shifts due to 
treatment and/or disease state are concealed, for further analysis only comparable samples 
were included into the various analysis. As the PCoA calculated using Qiime and visualized by 
Emperor include 3 principal components, whereas the visualization using Megan only 
includes 2 principal components, in the following analyses, only the PCoA created using 
Emperor are used for analysis of the microbiome composition. 
 Influence of T-cell transfer on the composition of the intestinal microbiome 3.4.3
Injection of naïve CD4+ T-cells induced intestinal inflammation in Endohi mice whereas Endolo 
mice maintained homoeostasis (Figure 31). During development of colitis the composition of 
the gut microbiome of Endohi animals appeared to change drastically. The shift in the 
bacterial community is evident in Figure 32 A. The data sets representing day 0 are 
highlighted in green. The composition of the microbiome changed most during the first 3 
weeks after T-cell transfer, after which no further severe shifts could be detected so later 
data points are located in close proximity of each other in the PCoA (highlighted by the white 
mark). The microbes colonizing the gut of mice that stayed healthy, however, did not appear 
to be greatly affected after T-cell transfer (Figure 32 B). Even though a shift took place within 
the first 3 weeks, the bacterial community seemed to return to the original composition 
within the monitored 6 week period. The datasets of weeks 0 and 6 are therefore located 
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close to each other and those representing the samples collected in week 3 are found at a 
slight distance. 
 
Figure 31: The histological colitis score quantifies the inflammation of the colon of mice. Whereas Endohi mice 
developed colitis approximately 6 weeks after T-cell transfer, Endolo mice remained healthy. Statistical 
analysis was done using Student t Test. * p<0.05 
 
Figure 32: PCoA of Endohi (A) and Endolo (B) mice treated with T-cells. During colitis development a shift of 
the microbiota was seen (A), whereas the microbiota of mice that maintained homeostasis showed slight 
variations of their microbiome after 3 weeks but returned towards the initial composition. The figure was 
created using Emperor.  
Independent of the software or algorithm used for computing the PCoAs, the reads of the 
different bacteria present could be associated with the corresponding taxa, thus enabling 
studies of the gut microbiome on different taxonomic levels. The composition on the phylum 
and genus level of the Endohi mice before as well as 3 and 6 weeks after T-cell transfer is 
shown in Figure 33, Figure 34 and Figure 35, which were created by Jörg Bernhardt using the 
Paver software (Decodon)185. The read associations for the taxonomic levels class, order and 
family are included in the Appendix. The darker the coloring, the more reads were mapped 
to a certain taxa. According to the sequencing reads, the amount of Firmicutes slightly 
decreased during development of colitis whereas Bacteroidetes reads increased. Although 
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the total amount of reads mapping to Firmicutes decreased after disease onset, the variety 
of different Firmicutes species detected in sick mice increased as disease progressed. 
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Figure 33: The composition of Endohi mice prior to T-cell transfer (n=7; all mice were part of experiment 3). The left picture shows the correlation of the sequencing reads 
with taxonomy on phylum level. In the right picture, the reads were associated with the corresponding taxonomy on the genus level where possible. Reads that could not be 
assigned to a genus were declared as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, the more reads were 
associated with the corresponding taxon. 
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Figure 34: The composition of Endohi mice 3 weeks after T-cell transfer (n=7; all mice were part of experiment 3). The left image shows the correlation of the sequencing 
reads with taxonomy on phylum level. In the right diagram, the reads were associated with the corresponding taxonomy on the genus level where possible. Reads that could 
not be assigned to a genus were declared as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, the more reads were 
associated with the corresponding taxon. 
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Figure 35: The composition of Endohi mice 6 weeks after T-cell transfer (n=7; all mice were part of experiment 3). The left image shows the correlation of the sequencing 
reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where possible. Reads that could 
not be assigned to a genus were declared as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, the more reads were 
associated with the corresponding taxon. 
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The exact opposite, an increase in Firmicutes and decrease in Bacteroidetes, was observed 
for mice that stayed healthy after T-cell transfer (Figure 36, Figure 37 and Figure 38). As 
observed for the Firmicutes in Endohi mice, the Endolo mice showed an overall decrease in 
reads mapping to Bacteroidetes, but the genera of Rikenellacaea increased during the 
experiment. The phylum of Verrucomicrobia decreased after T-cell transfer and could not be 
detected 3 weeks later; however, they did recover before the end of the experiment in week 
6. A steady increase of Tenericutes and bacteria not associated to a phylum was seen post T-
cell transfer. The variety of genera detected in the fecal samples of the Endolo mice did not 
differ between starting and end point, but did slightly decrease in between. 
Figures 33 - 38 also show that Proteobacteria (visible only on genus level) were only 
detectable within the microbiota of the Endohi mice that developed colitis. These results also 
indicated that the overall variety of detectable genera was greater in Endohi mice than in 
Endolo mice. The proportion of Bacteroidetes was also greater in Endolo mice than in Endohi 
mice, and the fraction of Firmicutes was smaller in Endolo mice. Tenericutes seemed to 
increase in both groups after T-cell transfer. 
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Figure 36: The composition of Endolo mice prior to T-cell transfer (n=5; all mice were part of experiment 4). The left image shows the correlation of the sequencing reads 
with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where possible. Reads that could not be 
assigned to a genus were declared as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, the more reads were 
associated with the corresponding taxon. 
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Figure 37: The composition of Endolo mice 3 weeks after T-cell transfer (n=5; all mice were part of experiment 4). The left image shows the correlation of the sequencing 
reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where possible. Reads that could 
not be assigned to a genus were declared as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, the more reads were 
associated with the corresponding taxon. 
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Figure 38: The composition of Endolo mice 3 weeks after T-cell transfer (n=5; all mice were part of experiment 4). The left image shows the correlation of the sequencing 
reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where possible. Reads that could 
not be assigned to a genus were declared as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, the more reads were 
associated with the corresponding taxon. 
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To verify the results on Enterobacteriaceae and Bacteroides of the NGS microbiome analysis, 
FISH was performed on samples collected 6 weeks post T-cell transfer. Representative 
photomicrographs of the outcome are shown in Figure 39. In contrast to NGS, no 
Enterobacteriaceae were detected in the sample of the Endohi mouse. Bacteroides were only 
detected by FISH in samples collected from Endolo mice. NGS, however, did not detect 
Bacteroides, only Bacteroidales in samples collected from Endohi and Endolo animals. 
 
Figure 39: FISH analysis showing the representative composition of bacteria present in the feces of Endohi (A) 
and Endolo (B) mice 6 weeks after T-cell transfer. All bacteria present were stained using DAPI while 
Enterobacteriaceae were stained red with a Cy3-labeled probe and Bacteroides were colored green by an 
Alexa Fluor 488 linked probe. No Enterobacteriaceae could be detected in either sample. Bacteroides were 
present in the Endolo sample, indicated by white arrows.  
 Feeding bacteria influences the intestinal microbiome 3.4.4
The LPS of gram-negative bacteria is recognized by the mammalian immune system. 
Depending on the structure of the Lipid A of LPS, different biological activity has been 
observed 69. Some bacteria therefore seem to be immune stimulating whereas others 
appear to inhibit immune reaction63,82. This, combined with our results showing that mice 
with a high endotoxic microbiome developed colitis and those harboring a low endotoxic 
microbiome didn’t, led us to the hypothesis that, changing the endotoxicity of the intestinal 
microbiome prior to T-cell transfer by feeding of high or low endotoxic bacteria could 
influence colitis development. Prof. R. Darveau from the University of Washington in Seattle 
kindly provided us with a high endotoxic E. coli strain (E. coli JM83; E. coliWT) and a low 
endotoxic mutant of this strain (E. coli JM83 htrBhtrBpg; E. coli MUT). The difference between 
the two bacterial strains lies in the structure of their LPS; the wild-type strain Lipid A 
contains a Laurate molecule. In the Lipid A molecule of the mutant strain, this Laurate is 
substituted by a palmitic acid, changing the endotoxicity of the LPS molecule from high to 
low. 
To test our hypothesis, Endolo and Endohi animals were fed E. coliWT or E. coliMUT prior to T-cell 
transfer. Antibiotics were given to the animals before treatment with bacteria to weaken 
colonization resistance of the initial microbiome, enabling colonization by the bacterial 
strains fed to the animals.  
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The experimental setup to study the influence of the two bacterial strains on the 
composition of the microbiome and development of colitis is shown in (Figure 40). Six days 
prior to T-cell transfer, animals were treated with antibiotics for 3 days through their 
drinking water. Endohi mice were treated with 20 g/l Streptomycin due to the high amount 
of gram- bacteria of their initial microbiome. Enodlo mice were treated with 1 g/l 
Metronidazole targeting anaerobic bacteria such as Bacteroides. Three days before T-cell 
transfer, the mice were treated with 1 x 108 bacteria i.g. Feeding of bacteria continued over 
the course of the experiment via drinking water. The first fecal samples for analysis of the 
intestinal microbiome were collected immediately before T-cell transfer on day 0. Further 
fecal samples were collected and frozen at -80 °C in week 3 and at the end of the experiment 
in week 6.  
 
Figure 40: Endolo and Endohi mice were treated with metronidazole and streptomycin, respectively, 6 days 
prior to T-cell transfer. Three days before T-cell transfer, the animals were treated with 1 x 108 bacteria i.g. 
and via drinking water for the rest of the experiment. On day 0, 5 x 105 naïve CD4+ T-cells were transferred. 
Fecal samples were collected on day 0 prior to T-cell transfer as well as 3 and 6 weeks after T-cell transfer. 
Mice treated with E. coliWT developed colitis irrespective of the original microbiota (Endo
hi or 
Endolo) (Figure 41). Approximately 4 weeks after T-cell transfer the first signs of colitis were 
visible; the mice first developed diarrhea followed by a display of a relieving posture and 
weight loss. 
In contrast, mice treated with E. coliMUT maintained homoeostasis and did not develop colitis 
within the 6 weeks of the experiment, irrespective of the initial microbiota (Figure 41). The 
inflammation of the colon was quantified by the histological colitis score and was used to 
distinguish between healthy and diseased mice. 
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Figure 41: The histological colitis score shows that animals fed with E. coliWT develop colitis and animals fed 
with E. coliMUT maintain homoeostasis irrespective of the initial Endolo or Endohi microbiome. Statistical 
analysis was done using Student t Test. * p<0.05. 
3.4.4.1 Treatment with E. coliWT induces colitis  
Colonizing Endohi animals with E. coliWT prior to T-cell transfer did not change the health 
state of the mice at the end of the experiment. These mice developed the same indicators 
for disease as the non-pre-treated Endohi mice.  
Visualization of sequencing reads on the phylum level showed no Proteobacteria for non-
pre-treated Endohi mice, but they were apparent in E. coliWT fed animals. The proportion of 
Proteobacteria was primarily influenced by the reads mapping to the genus Escherichia. No 
major changes of the Firmicutes were evident during the experiment; an increase of 
Tenericutes was seen between week 3 and 6 and no Bacteroidetes could be detected. The 
variety of genera detected in samples from Endohi mice fed with E. coliWT was greater at the 
end of the experiment than in week 0. 
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Figure 42: Composition of the intestinal microbiota of E. coliWT treated Endohi mice before T-cell transfer (n = 2; animals were part of experiment 3). The left image shows the 
correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where 
possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The darker the 
color, the more reads were associated with the corresponding taxon. 
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Figure 43: Composition of the intestinal microbiota of E. coliWT treated Endohi mice, 3 weeks after T-cell transfer (n = 2; animals were part of experiment 3). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 44: Composition of the intestinal microbiota of E. coliWT treated Endohi mice 6 weeks after T-cell transfer (n = 2; animals were part of experiment 3). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Colonizing Endolo mice with E. coliWT prior to T-cell reconstitution resulted in the 
development of colitis. Figures 45 - 47 show that although E. coliWT was fed prior to T-cell 
transfer in week 0, and during the complete timespan of the experiment, Proteobacteria 
remained below the limit of detection and was only visible on the family level (0 Appendix) 
or lower in week 6. Changes of the microbiota between week 0 and week 6 appeared to be 
similar in non- and E. coliWT pre-treated Endo
lo animals on the phylum level with one 
exception: the increase of bacteria that could not be associated to a phylum seen in non-pre-
treated mice did not appear in mice fed with E. coliMUT.  
Resolving the sequencing data on the genus level indicated that generally the same genera 
could be detected in the microbiome of E. coliWT Endo
lo animals and Endolo animals that only 
had T-cells transferred. Although some fluctuation is seen in the relative amounts of the 
different genera, the genera themselves did not change substantially. 
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Figure 45: Composition of the intestinal microbiota of E. coliWT treated Endolo mice before T-cell transfer (n = 5; animals were part of experiment 4). The left image shows the 
correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where 
possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The darker the 
color, the more reads were associated with the corresponding taxon. 
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Figure 46: Composition of the intestinal microbiota of E. coliWT treated Endolo mice, 3 weeks after T-cell transfer (n = 5; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
 Results 
 
80 
 
Figure 47: Composition of the intestinal microbiota of E. coliWT treated Endolo mice, 6 weeks after T-cell transfer (n = 5; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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FISH analysis of feces collected in week 6 from E. coliWT treated Endo
hi and Endolo mice 
confirmed the findings of the sequencing experiments. Bacteroides were only found within 
the samples of E. coliWT treated Endo
lo mice and Enterobacteriaceae were sporadically found 
in the Endohi animals treated with E. coliWT but not in the E. coliWT treated Endo
lo mice 
(Figure 48). 
 
Figure 48: FISH of representative samples collected from E. coliWT treated Endohi (A) and Endolo (B) mice in 
week 6. DAPI staining visualizes all bacteria, Enterobacteriaceae are labeled by Cy3 (red) and Bacteroides by 
Alexa Fluor 488 (green). Enterobacteriaceae were only detected in samples from Endohi animals and 
Bacteroides only in samples collected from the Endolo mice. 
3.4.4.2 Treatment of mice with E. coli JM83 mutant strain prevents colitis 
Feeding of E. coli JM83 ΔhtrBhtrBpg (E. coliMUT) to Endo
hi animals prior to T-cell transfer 
resulted in maintenance of homoeostasis. On the day of T-cell transfer, no Bacteroidetes 
were detected, but the Proteobacteria are evident, with most reads mapping to Escherichia. 
During the course of the experiment, the Proteobacteria fell below the detection limit and 
Bacteroidetes and Tenericutes were detected for the first time. 
The bacterial composition and the changes of the intestinal microbiome of the E. coliMUT 
treated Endohi mice (Figures 49 - 51) were similar to the Endohi mice without bacterial pre-
treatment (Figures 33 - 35). The main difference between these two groups was that 
Proteobacteria were only detectable on the day of T-cell transfer in the E. coliMUT pre-treated 
mice. The bacterial diversity on genus level, however, was lower than the only T-cell treated 
Endohi mice. The variety of identified genera was greater in the microbiome after disease 
development. 
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Figure 49: Composition of the intestinal microbiota of E. coliMUT treated Endohi mice, before T-cell transfer (n = 2; animals were part of experiment 3). The left image shows 
the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level 
where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 50: Composition of the intestinal microbiota of E. coliMUT treated Endohi mice, 3 weeks after T-cell transfer (n = 2; animals were part of experiment 3). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 51: Composition of the intestinal microbiota of E. coliMUT treated Endohi mice, 6 weeks after T-cell transfer (n = 2; animals were part of experiment 3). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figures 52 - 54 show that despite colonizing Endolo mice with E. coliMUT prior to T-cell 
transfer and via the drinking water during the entire experiment, the amount of 
Proteobacteria remained below the limit of detection. On the phylum level the only obvious 
changes of microbiota composition was the decrease of Bacteroidetes between weeks 0 and 
3, followed by their increase and the steady increase of Tenericutes. The abundances of the 
reads mapping to the different genera differed slightly over the course of the experiment, 
however, the genera with which the reads were associated to did not change substantially.
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Figure 52: Composition of the intestinal microbiota of E. coliMUT treated Endolo mice, before T-cell transfer (n = 5; animals were part of experiment 4). The left image shows 
the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level 
where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 53: Composition of the intestinal microbiota of E. coliMUT treated Endolo mice, 3 weeks after T-cell transfer (n = 5; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 54: Composition of the intestinal microbiota of E. coliMUT treated Endolo mice, 6 weeks after T-cell transfer (n = 5; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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FISH of samples collected in week 6 from E. coliMUT treated Endo
hi and Endolo animals is 
shown in (Figure 55). Bacteroides were detected in the sample of the Endolo animals, but not 
in the Endohi animals. As the proportion of Bacteroides was higher in the microbiome of 
Endolo animals than that of Endohi animals, the failure to detect Bacteroides in Endohi 
animals might be due to the lower detection limit of FISH than NGS. The 16S analysis 
detected no Proteobacteria in week 6 in Endolo or Endohi animals. In contrast, FISH analysis 
showed hybridization of the Enterobacterial probe in the samples collected from Endohi 
mice.  
 
Figure 55: Representative composition of the bacteria present in the feces of E. coliMUT treated Endohi (A) and 
Endolo (B) mice 6 weeks after T-cell transfer analyzed by FISH. All bacteria present were stained by DAPI 
while Enterobacteriaceae were stained red with a Cy3 labeled probe and Bacteroides were colored green by 
an Alexa Fluor 488 linked probe. 
 The LPS expressed by bacteria fed decides on the disease state 3.4.5
In theory, the only difference between the two E. coli strains used for the experiments 
described above is the structure of the LPS. The Lipid A of the isolated LPSMUT contained 
palmitic acid in addition to Laurate. The Lipid A of LPSWT contained only Laurate 
69. This 
indicates that the structure of the LPS decides the colitogenic potential of the bacteria. 
Creating a mutant strain, however, could also cause other non-evident changes to the 
bacterium that could affect the pro- or anti-inflammatory potential. To confirm LPS as the 
molecule responsible for the outcome of the experiments, wild-type and mutant LPS (LPSWT 
and LPSMUT) were isolated and fed to the mice.  
To study the impact of LPSWT and LPSMUT on the composition of the microbiota, an 
experimental setup analogous to that used to study the impact of feeding complete bacteria 
was chosen (Figure 56). 160 µg LPS, equivalent to 1 x 108 bacteria, was given i.g. Mice were 
also fed with LPS through their drinking water during the rest of the experiment. 2 mg of LPS 
were added to their water per week, which was refilled to 250 ml. 
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Figure 56: Endolo and Endohi mice were treated with metronidazole and streptomycin, respectively, for 3 days 
beginning 6 days prior to T-cell transfer. Three days before T-cell transfer, the animals were treated with 
160 µg LPS i.g. and 2 mg /week via drinking water for the following course of the experiment. 5 x 105 naïve 
CD4+ T-cells were transferred on day 0. Fecal samples were collected on this day prior to T-cell transfer as 
well as 3 and 6 weeks after T-cell transfer and frozen at -80°C. 
As when mice were fed viable bacteria, irrespective of the initial microbiota, mice fed with 
LPSWT developed colitis whereas mice fed with LPSMUT maintained homoeostasis (Figure 57).  
 
Figure 57: Irrespective of the initial microbiota (Endolo or Endohi), mice maintained homoeostasis if they were 
fed with LPSMUT but developed colitis after feeding of LPSWT. Histological colitis score of animals fed with 
LPSMUT vs. LPSWT irrespective of the initial microbiota. Statistical analysis was performed using the Student t-
test, * indicates p <0.05. 
The composition of the intestinal microbiome of Endohi animals treated with LPSWT on day 0, 
week 3 and week 6 are shown in Figures 58 - 60. Feeding of LPSWT to Endo
hi animals prior to 
T-cell reconstitution induced colitis. In week 0 no Bacteroidetes were detected; (Figure 58), 
however, this phylum increased throughout the first 3 weeks post T-cell transfer (Figure 59). 
The microbiota on day 0 was only made up of Firmicutes, or more precisely, the microbiome 
only contained Bacilli. The Endohi animals that were not pre-treated with bacteria or LPS also 
contained Bacteroidetes and Clostridia in their microbiome on day 0. During the first 3 
weeks of the experiment these bacterial groups also appeared in the microbiome of the 
LPSWT treated Endo
hi mice. The Tenericutes that appeared in the microbiome of the T-cell 
only treated Endohi mice in week 3 were detected in the sample collected in week 6 of the 
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LPSWT treated Endo
hi mice. These mice show an increasing diversity of their intestinal 
microbiome over the course of the experiment.  
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Figure 58: Composition of the intestinal microbiota of LPSWT treated Endohi mice, before T-cell transfer (n = 3; animals were part of experiment 7). The left image shows the 
correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where 
possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The darker the 
color, the more reads were associated with the corresponding taxon. 
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Figure 59: Composition of the intestinal microbiota of LPSWT treated Endohi mice, 3 weeks after T-cell transfer (n = 3; animals were part of experiment 7). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 60: Composition of the intestinal microbiota of LPSWT treated Endohi mice, 6 weeks after T-cell transfer (n = 3; animals were part of experiment 7). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figures 61 - 63 show the composition of the intestinal microbiome of Endolo mice pre-
treated with LPSWT. These mice developed colitis during the course of the experiment in the 
same way as the E. coliWT treated Endo
lo mice. Both groups of mice showed very similar 
intestinal microbiome compositions over the whole course of the experiment. High amounts 
of Bacteroidetes decreased during the 6 weeks whereas Firmicutes showed no apparent 
change. Verrucomicrobia were present in the samples collected on day 0 and week 6, but 
not in week 3, and Tenericutes increased during the experiment. All of this however was also 
found in the T-cell only treated Endolo animals. The only difference on phylum level seen 
between the two Endolo groups that develop colitis, and the T-cell only treated group that 
stays healthy, is that the microbiome of the latter group also contains an increasing 
proportion of sequencing reads that could not be associated to a phylum.
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Figure 61: Composition of the intestinal microbiota of LPSWT treated Endolo mice, before T-cell transfer (n = 4; animals were part of experiment 4). The left image shows the 
correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where 
possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The darker the 
color, the more reads were associated with the corresponding taxon. 
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Figure 62: Composition of the intestinal microbiota of LPSWT treated Endolo mice, 3 weeks after T-cell transfer (n = 4; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 63: Composition of the intestinal microbiota of LPSWT treated Endolo mice, 6 weeks after T-cell transfer (n = 4; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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The portions of Bacteroides and Enterobactereaceae in the samples collected in week 6 from 
Endohi and Endolo mice treated with LPSWT were also analyzed by FISH (representative 
samples are shown in Figure 64). These results confirmed the NGS results; more Bacteroides 
were present in the Endolo group and no Enterobacteriaceae were detected in either sample. 
In contrast to the sequencing results, no Bacteroides could be found in the Endohi LPSWT 
group. 
 
Figure 64: FISH of representative samples collected from LPSWT treated Endohi (A) and Endolo (B) mice in 
week 6. DAPI staining visualizes all bacteria, Enterobacteriaceae are labeled by Cy3 (red) and Bacteroides by 
Alexa Fluor 488 (green). 
Feeding of LPSMUT to Endo
hi or Endolo animals prevented colitis development, as did 
treatment with E. coliMUT (Figure 57).  
The intestinal microbiome of LPSMUT treated Endo
hi mice on day 0 contained mainly 
Bacteroidetes and Firmicutes (Figure 65). Small amounts of bacteria that could not be 
assigned to a phylum, and Tenericutes were also detected. The proportions of Bacteroidetes 
were higher than in T-cell only treated Endohi mice and decreased during the first 3 weeks of 
the experiment but increased again during the last 3 weeks. The amount of different genera 
belonging to the phylum Bacteroidetes present in the microbiome of Endohi mice treated 
with LPSMUT was higher than in T-cell only treated Endo
hi animals. 
 Results 
 
100 
 
Figure 65: Composition of the intestinal microbiota of LPSMUT treated Endohi mice, before T-cell transfer (n = 5; animals were part of experiment 3). The left image shows the 
correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where 
possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The darker the 
color, the more reads were associated with the corresponding taxon. 
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Figure 66: Composition of the intestinal microbiota of LPSMUT treated Endohi mice, 3 weeks after T-cell transfer (n = 5; animals were part of experiment 3). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 67: Composition of the intestinal microbiota of LPSMUT treated Endohi mice, 6 weeks after T-cell transfer (n = 5; animals were part of experiment 3). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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The intestinal microbiota of Endolo animals fed with LPSMUT contained a high proportion of 
Bacteroidetes, Firmicutes, and Tenericutes on day 0 (Figure 68). During the experiment, the 
reads associated to Bacteroidetes decreased. Tenericutes were also detected in the sample 
collected in week 6, but not in week 3. Reads that could not be associated to a phylum were 
only found in the samples collected in week 6. Verrucomicrobia (genus Akkermansia) were 
detected in week 3 and week 6 after T-cell transfer (Figures 68 - 70). 
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Figure 68: Composition of the intestinal microbiota of LPSMUT treated Endolo mice, before T-cell transfer (n = 4; animals were part of experiment 4). The left image shows the 
correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus level where 
possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The darker the 
color, the more reads were associated with the corresponding taxon. 
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Figure 69: Composition of the intestinal microbiota of LPSMUT treated Endolo mice, 3 weeks after T-cell transfer (n = 4; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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Figure 70: Composition of the intestinal microbiota of LPSMUT treated Endolo mice, 3 weeks after T-cell transfer (n = 4; animals were part of experiment 4). The left image 
shows the correlation of the sequencing reads with taxonomy on phylum level. In the right image, the reads were associated with the corresponding taxonomy on the genus 
level where possible. Reads that could not be assigned to a genus were declared as „others“ of the lowest taxonomic  level possible. The figures were created using Paver. The 
darker the color, the more reads were associated with the corresponding taxon. 
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FISH analyses of samples collected in week 6 of the Endohi and Endolo animals treated with 
LPSMUT confirmed the findings of the sequencing analysis. More Bacteroides were detected 
in the sample from Endohi animals (A) than Endolo (B) mice (Figure 71). Enterobacteriaceae 
were not detectable in either sample. 
 
Figure 71: representative FISH analysis of samples collected in week 6 from Endohi (A) and Endolo (B) animals 
treated with LPSMUT. DAPI staining visualizes all bacteria, Enterobacteriaceae are labeled by Cy3 (red) and 
Bacteroides by Alexa Fluor 488 (green). Bacteroides were detected in Endohi and Endolo mice. 
 Metagenomics 3.4.6
Mammalian intestines are not only colonized by bacteria, but also by microorganisms such 
as viruses and archaea. To analyze the complete composition of the microbiota, shotgun 
metagenomic analysis can be used. These analyses also give information about the functions 
that can be carried out by the microorganisms. The bacterial composition of the intestinal 
microbiota can vary extremely between individuals, or even over time within the same 
individual. As different bacteria can perform the same tasks, however, variability between 
samples can be lower on the functional level. As no bacterial species or bacterial 
composition could conclusively be linked to colitis development, additional experiments 
were performed to analyze the complete microbial composition of the intestinal microbiota 
as well as the functions that could be performed by the microorganisms. 
Other experiments have shown that application of antibiotics, as done for the experiments 
to analyze the bacterial composition of the gut microbiome, is not necessary to influence the 
development of colitis by treatment with high or low endotoxic bacteria. No antibiotic 
treatment was therefore performed for the shotgun metagenome experiments. In addition 
to prevention of colitis by feeding low endotoxic bacteria before T-cell transfer, we also 
wanted to study the potential of low endotoxic bacteria to treat colitis. The experimental 
setup used for these studies is described in figures 72-75.  
Endohi mice were transferred with 5 x 105 CD4+ naïve T-cells on day 0 and developed colitis 
over the next 4 weeks. Fecal samples were collected just before T-cell transfer and kept on 
ice until frozen at -80 °C. Additional fecal samples were collected in week 4 and 6 after T-cell 
transfer.  
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Figure 72: Experimental setup for shotgun metagenomic analysis of Endohi mice transferred with naïve 
CD4+ T-cells. Approximately 4 weeks after T-cell reconstitution, the animals show first signs of disease. 
A second group of Endohi mice were treated in the same way but additionally treated with 
low endotoxic Bacteroides vulgatus mpk (1 x 108 bacteria) 3 days prior to T-cell 
reconstitution. The bacterial treatment was continued via the drinking water during the 
complete experiment. Fecal samples were collected as described for the first group on day 0 
as well as in weeks 4 and 6 after T-cell transfer. These animals did not show signs of colitis.  
 
Figure 73: Experimental setup for analyzing the impact of preventive B. vulgatus treatment in Endohi mice 
transferred with naïve CD4+ T-cells. Mice pretreated with B. vulgatus maintain homeostasis.  
A third group of Endohi mice were also reconstituted with T-cells on day 0. In week 4 after T-
cell transfer, these mice were treated with B. vulgatus mpk i.g (1 x 108 bacteria). Bacterial 
treatment continued for the rest of the experiment through the drinking water of the mice. 
The experiment with these mice continued for 8 weeks. Fecal samples were collected as in 
the other groups on day 0, in week 4 before B. vulgatus application, in week 6 and in week 8. 
Diarrhea, indicating disease onset that was present in week 4 improved or even disappeared 
after treatment with B. vulgatus.  
 
 
Figure 74: Experimental setup for analysing the impact of colitis and intervention by treantment with 
B  vulgatus, on the microbiome using shotgun metagenomics.  
 Results 
 
109 
To monitor the changes of the intestinal microbiota that were not related to the treatment 
or colitis development but due to environmental factors, an untreated control group was 
included. Fecal samples of these mice were collected at the same time as those of the other 
groups, on day 0, and in weeks 3, 6 and 8. 
 
Figure 75: Experimental setup of the reference group for monitoring the impact of environmental factor on 
the metagenome.  
The DNA was isolated from all the samples as described 2.2.12.2 DNA isolation. Sequencing 
and analysis of these samples is the subject of ongoing studies. 
 Transcriptomics 3.4.7
Analyzing the 16S genes from a fecal sample is a way to identify bacterial species colonizing 
the gut of an individual. By studying total DNA (shotgun metagenomics) instead of 
amplicons, all the genes present within the intestinal microbiome can be evaluated and 
conclusions can be drawn about the hypothetical functional complexity provided by the 
intestine’s bacterial population. The simple presence of a gene, however, does not imply 
that it is active. By studying the RNA found within a sample instead of the DNA, the 
discrepancy can be reduced between the genes present and those actually influencing 
functions of the microbiome. Only the active genes are translated into mRNA and have the 
ability to impact the features of the microbiota. The potential for false associations between 
a phenotype and the role of the bacterial community within the gut can be reduced by 
studying transcriptomics instead of metagenomics. 
Previous experiments have shown that low endotoxic bacteria can prevent colitis 
development, whereas high endotoxic bacteria trigger colitis. In the course of other projects, 
germ-free mice were colonized with E. coli mpk and/or B. vulgatus mpk. IL2-/- mice colonized 
with E. coli mpk developed colitis, while those colonized with B. vulgatus mpk stayed 
healthy, as did mice colonized with both bacterial strains 82,186. It is therefore interesting to 
analyze how the bacteria influence each other and the host. Studying which genes are 
expressed in the different colonization scenarios can help to understand what triggers colitis, 
and how B. vulgatus mpk prevents E. coli mpk induced colitis development. 
For this study, germ-free C57Bl/6 mice were colonized with E. coli mpk through the drinking 
water. After 4 weeks, fecal samples for transcriptomics were collected and frozen in 
RNAprotect bacteria at -80 °C. 
A second group of mice was colonized with B. vulgatus mpk through the drinking water. 
Fecal samples for transcriptomics from these mice were also collected 4 weeks later.  
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The mice colonized with both bacterial strains were first colonized with E. coli mpk und 5 
weeks later colonized with B. vulgatus mpk through their drinking water. Fecal samples for 
transcriptomics were collected 8 weeks after the first colonization and frozen as described 
above.  
The samples were used to establish RNA isolation for transcriptomic analysis. Further 
analysis is a part of ongoing studies. 
RNA was isolated from fecal samples as described in 2.2.13.2 RNA isolation. The quality of 
the isolated RNA was checked using a Bioanalyzer 2100 and the RNA nano kit. The 
electropherogram of RNA isolated from freshly collected mouse feces is depicted in Figure 
76 A. The typical peaks for bacterial 16S and 23S ribosomal RNA (rRNA) were clearly visible. 
A third peak within the 5S rRNA region indicated accumulation of small RNA fragments. This 
analysis showed no signs of RNA degradation. A bump in the electropherogram under the 
16S and 23S rRNA peaks indicated DNA contamination. Applying DNase treatment removed 
DNA residues (Figure 76 B). The amount of 1 000 – 4 000 bases long nucleic acids was 
reduced and a second peak within the 5S rRNA region marked in Figure 76 A was also 
eliminated. 
 
Figure 76: RNA isolated from fecal samples of conventionally colonized mice were contaminated by DNA 
residues (A) that were eliminated by DNase treatment. (B). The RNA quality was analyzed using a Bioanalyzer 
2100 (Agilent). The RNA was loaded onto a RNA chip using the RNA nano reagents.  
Feces from germfree animals should only contain host RNA or ribonucleic acids that were 
part of the diet. These samples were used to determine the amount of contaminating RNA 
not originating from intestinal bacteria. As shown in Figure 77 no 16S or 23S rRNA could be 
detected within these samples. A very small amount of RNA within the 5S rRNA region was 
visible, however in much lower concentrations compared to samples from conventional 
mice.  
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Figure 77: Electropherogram of RNA isolated from feces of germfree mice. 
Isolation of RNA using the Zymo Research kit “Soil/Fecal RNA MicroPrep” from cultured 
bacteria shows the same peaks in the electropherogram (Figure 78) as already seen for the 
conventional mice (Figure 76).  
 
Figure 78: Next to the expected 16S and 23S rRNA, RNA isolated from cultured bacteria with the Soil/Fecal 
RNA MicroPrep kit contains large amounts of small RNA. Electropherogram created using a Bioanalyzer 2100 
and the RNA nano reagents of RNA isolated from cultivated B. vulgatus. 
In order to determine whether RNA has to be isolated from fresh fecal samples or if the 
samples can be frozen and collected before retrieving the RNA, samples were collected and 
stored at different conditions. For each group three samples were analyzed. The conditions 
tested were fresh and frozen native samples as well as fresh and frozen samples 
homogenized in RNAprotect Bacteria. Figure 79 shows representative electropherograms for 
each group of samples. No obvious differences were apparent between the fresh samples 
and the samples frozen in RNAprotect Bacteria. The amount of shorter RNA fragments 
increased in native frozen samples. The ratio of 16S and 23S rRNA was also different in these 
samples compared to the other RNA isolates. For metatranscriptomic analysis the RNA from 
fecal samples should therefore be isolated immediately after sample collection or frozen in 
RNAprotect Bacteria at -80 °C until the RNA can be isolated. 
 Results 
 
112 
 
Figure 79: Elektropherograms of RNA isolated from fecal samples of conventional mice. Fecal samples were 
either homogenizedin RNAprotect Bacteria or native and were used freshly or frozen previous to RNA 
isolation. Freezing of native fecal samples leads to RNA degradation, whereas the three other conditions do 
not show apparent differences. 
RNA stability was further assessed by analyzing its quality after a cycle of freezing and 
thawing. The electropherograms (Figure 80 A and B) show an increase of short and decrease 
of long RNA sequences indicating RNA degradation. RNA should therefore be transcribed 
into DNA immediately after isolation and not frozen previous to this step. 
 
Figure 80: Electropherogram of isolated RNA immediately after isolation (A) and after freezing and thawing 
(B). Freezing the RNA after isolation leads to RNA degradation, therefore only freshly isolated RNA should be 
used for reverse transcription and subsequent sequencing.  
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4. Discussion 
4.1 Establishment of Methods 
 qPCR: verification of primer specificities 4.1.1
Quantitative real-time PCR (qPCR) is a method for determining the amount of defined DNA 
copies in a sample. Samples with defined concentrations are used to determine absolute 
amounts of DNA. Without standards, relative quantities of DNA can be determined by 
comparing multiple samples.  
Primer specificity determines which defined DNA sequences can be analyzed. Primer 
sequences were selected from publications or designed in silico based on publicly available 
bacterial genome sequences (www.ncbi.nlm.nih.gov). The specificity of the chosen primers 
was validated in two steps. First, a Primer-BLAST search was conducted for each primer pair 
to determine its specificity. The results of these searches, however, are only as good as the 
reference database and the results vary depending on parameter selection. In addition to 
computational analysis, species specificity was ensured in an experimental approach. DNA 
was isolated from a variety of different bacteria representing many bacterial phyla, classes, 
orders, families and genera. It is widely accepted that bacteria can be grouped according to 
the sequence identity of their 16S rRNA gene 164,165. Selection of primers complementary to 
extremely conserved regions will amplify a wide variety of bacteria and can therefore be 
used as universal primers. Designing primers to variable regions is useful to target subsets of 
bacteria. Depending upon the degree of variance of the primer binding site, bacteria 
grouped at different taxonomic levels can be targeted. Regions of high variability will be 
chosen to differentiate bacteria on a species level. The closer the phylogenic relationship 
between bacteria, the more likely a primer set will amplify both strains and lead to a false 
positive result. The bacterial strains chosen for experimental validation of primer specificity 
were selected to include closer and more distantly related species to cover different 
specificity levels. The primers used for quantification of B. vulgatus and B. dorei did not 
amplify other members of the genus Bacteroides and were therefore considered to be 
specific for these two closely related species. Another primer set could be used to detect all 
the members of the order Bacteroidales included in the experiments. The experimental 
approach verified the results of the in silico sequence comparison, indicating that the 
selected primers were specific for the targeted bacteria. 
Amplification efficacy is important for calculation of the template concentration. 
Theoretically, during one cycle of amplification every template strand is doubled. After n 
cycles the initial concentration will accordingly be increased by a factor of 2n. However, in 
reality the amplification efficiency is slightly lower, including factors such as less-than-
optimal primer properties, PCR inhibitors in the sample, or primer dimerization 187,188. By 
amplification of defined template dilutions, it is possible to calculate the efficiency of a 
primer set. This is done by plotting the concentration vs. the threshold cycle and performing 
simple linear regression.  
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 Fluorescence in situ hybridization 4.1.2
Fluorescence in situ hybridization (FISH) is a non-PCR dependent method and can therefore 
be considered independent from the sequencing and qPCR approaches. For this reason, the 
method was selected to verify the results of 454 sequencing. One great advantage of this 
method is that it is culture independent: if the DNA sequence of a bacterial strain is known, 
probes can be designed and bacteria can be detected directly in a sample.  
16S rRNA sequencing and qPCR are both based on PCR and are therefore likely to be biased 
in the same way. FISH on the other hand does not rely on amplification of DNA sequences, 
although similar to primers, specific probes are designed to detect certain bacteria. This 
method is therefore targeted and cannot be used for the identification of unknown bacteria 
or bacteria that have not been sequenced.  
An additional limitation of this method is the high threshold for the detection of bacteria. 
This is because only a very small amount of sample is analyzed, and it must be diluted 
enough to ensure single bacteria can be identified. Bacteria which are present in low 
concentrations are therefore unlikely to be detected.  
Our results show that bacteria can be detected in stool samples by FISH. We were able to 
establish a protocol without the need to remove stool particles prior to probe hybridization. 
The background fluorescence could clearly be distinguished from specific staining of the 
probes. 
Two different methods can be used for absolute quantification; 1: counting bacteria stained 
by a certain probe; 2. Determining the area stained by the probe in question 189,190. For 
counting bacteria, it has to be ensured that the sample is dilute enough to clearly identify 
single bacteria on the slide. Differences in morphology do not influence the count. 
Quantification of bacteria according to area stained will be biased by the size of the bacterial 
species. The larger a bacterial cell, the bigger the area will be that is colored by the probe. 
Comparison of a small and a large bacterial cell will therefore result in supposedly larger 
amounts of the bigger species. For exact quantification, normalization is necessary however, 
if groups of bacteria with different morphology are targeted, normalization becomes 
impossible. Relative quantification may also be useful, including cases where not all bacteria 
can clearly be separated from each other. The result will be somewhat biased but, an 
estimation of the relative amount is possible and useful.  
4.1.2.1 Probe selection  
Complete verification of sequencing results would require designing probes for all different 
taxonomic levels of the detected bacteria. We hypothesized, based on earlier experiments 
and published data that Bacteroides and Enterobacteriacae would be of interest in IBD 
development. Bacterial identification was limited to these groups and probes targeting all 
bacteria or specific for Enterobacteriaceae, Bacteroides or Bacteroides vulgatus were 
selected.  
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These targets were selected on the basis of published data indicating that certain B. vulgatus 
strains are able to inhibit E. coli induced colitis and the observation that Rag1-/- mice with 
high or low CFU counts of Bacteroidetes or Enterobacteriaceae, respectively, do not develop 
colitis after T-cell transfer, although genetically identical mice with opposite relative 
amounts of Bacteroidetes and Enterobacteriaceae did 41,183. In addition to these findings, 
metagenome analyses have associated IBD with altered Bacteroides and Enterobactericeae 
colonization 42,44,191. 
4.1.2.2 Multiple staining 
Staining one sample simultaneously with multiple probes reduces the workload and time 
necessary for determining the relative abundance of targeted bacteria. It also ensures that 
the conditions are consistent for all bacteria, ensuring comparability.  
A pre-requisite for simultaneous staining with various probes specific for different bacteria is 
that staining is successful using identical hybridization conditions. After a protocol was 
established that could be followed for staining with any of the selected probes, simultaneous 
staining with 3 probes was successfully attempted. Effective analysis of FISH using multiple 
probes strongly depends on the microscope, camera and filters used for visualization of the 
samples. Although the coloring of the bacteria could clearly be differentiated by eye, when 
using the Leica DMRE microscope, the signals originating from the Cy3, Flourescin or Alexa 
Fluor 488 dye were not clearly differentiated.  
The cameras used with our microscopes do not detect different colors, but only capture light 
signals. The color is added to the picture artificially by the software. The staining of bacteria 
in a multi-staining setting is therefore detected successively. The fluorescent dyes can be 
separated according to their varying wavelengths. In combination with the correct filter, the 
camera will only detect signals of a single dye. The light produced by the others, will not be 
able to pass the filter. Using the Zeiss CLSM 710 NLO instead of the Leica DMRE microscope 
solved the problem of detecting multiple dyes at once. These results show that the Zeiss 
CLSM 710 NLO should be preferred when analyzing FISH samples stained using Cy3 in 
combination with Alexa Fluor 488 or Flourescin. 
 DNA isolation from fecal samples 4.1.3
For analysis of the microbiome by 16S or shotgun metagenomics, DNA of the bacteria within 
the feces samples has to be isolated. The data resulting from DNA based identification of 
community members varies depending on the isolation method 180,192–195. The greatest 
difference between envelopes of different bacterial species is the structure of the cell-wall. 
Gram-positive (gram+) bacteria are much more stable than gram-negative (gram-). To ensure 
that gram+ bacteria are also lysed properly, samples were frozen and the protocol of the 
QIAamp DNA Stool Kit was modified to include an additional bead beating step and 
enzymatic lysis using Lysozyme 180,192,196. Bonot et al 195 tested 10 different DNA extraction 
protocols and only two methods, of which one was the QIAamp DNA Stool Kit, yielded DNA 
that could successfully be used for subsequent amplification. Different parameters were 
assessed for determining the quality of the extracted DNA. Purity was assessed 
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spectrophotometrically. The ratios of absorption at 260/280 nm and 260/230 nm provide an 
indication of possible contaminants, protein or carbohydrates, aromatic compounds, humic 
acids and phenolics, respectively. Ideally the 260/280 nm ratio is 1.8 and the 260/280 nm 
ratio is between 2.0 and 2.2 194. Using the QIAamp DNA Stool Kit usually yielded DNA that 
met these criteria. The extracted DNA was also tested for degradation by gel 
electrophoresis. Although a smear indicating slight degradation was seen for most of the 
samples, the majority was high molecular DNA of satisfactory integrity. The 16S rRNA gene 
region which was amplified and later sequenced is only approximately 700 bp long. Even the 
small amount of fragmented DNA present in some samples was longer than that, indicating 
that the amplification of the 16S rRNA gene fragment was not affected. 
Compared to the phenol-based DNA isolation used for DNA extraction for shotgun 
metagenomics, isolation with the QIAamp DNA Stool Kit was much faster and more samples 
could be processed simultaneously. The slightly lower quality, due to degradation, was 
accepted as a tradeoff, as only short DNA fragments were of interest for subsequent 
applications and amplicon generation did not seem to be affected. 
For shotgun metagenomics, the total DNA is sheared into fragments of defined length. Using 
non-degraded DNA as starting material minimizes the amount of sequences of incorrect 
length. Depending on the method used to fragment the DNA, sequence specific biases are 
introduced, which are exacerbated if degraded DNA is used as starting material and may 
even result in complete loss of genomic regions 197. For shotgun metagenomics of the 
intestinal microbiome, the DNA extracted using the QIAamp Stool Kit was not of high enough 
quality. DNA for this application was therefore isolated using a phenol-based DNA extraction 
method, yielding non-degraded DNA that was longer than 10 000 bp. Freezing of the 
samples at -80 °C and a bead-beating step were included to enhance lysis of gram+ bacteria 
and to minimize biases due to DNA isolation. 
 RNA isolation from fecal samples 4.1.4
RNA was isolated from fecal samples in preparation of transcriptomic analysis of the 
intestinal microbiome. Expression profiles can be used to identify specifically regulated 
genes under different environmental conditions. 
4.1.4.1 RNA quality 
RNA was isolated with the ZR Soil/Fecal RNA MicroPrep kit following manufacturer’s 
instructions. Quality control was done using an Agilent Bioanalyzer and the RNA 6000 Nano 
Kit. The electropherogram produced by the Bioanalyzer gives information on RNA integrity 
and amount. The analysis of the RNA using the Bioanalyzer is size-dependent separation of 
nucleic acids by gel electrophoresis 198. The small tRNA (4S) and the 5S rRNA will be detected 
within the same region and separated from 16S and 23S rRNA. The mRNA is not of defined 
length therefore, no defined peak can be associated to mRNA 199. As the mRNA only 
contributes 1-5 % to total RNA 171, it is not explicitly visible in the spectrum of total RNA. The 
ratio of 23S/16S rRNA (approximately 1.5 - 2 for good quality) is one of the most common 
used indicators for RNA integrity, however, exceptions to this rule do exist 200,201. If RNA is 
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degraded, the amount of short RNA strands increases and consequently the long strands 
decrease, which can be detected in the electropherogram. As a measure of RNA quality, the 
level of the baseline in the electropherogram was evaluated, which is increased across the 
entire RNA range if degradation occurs.  
The large amount of RNA accumulating within the range of the 5S rRNA was surprising. The 
result expected according to the documentation provided by Zymo Research for the RNA 
isolation kit and Agilent Technology on the RNA Nano assay were that only slight 
accumulation of RNA would occur in the 5S region. Degradation of RNA was ruled out, 
because if this had occurred, the complete baseline of the electropherogram would have 
been increased and the peak resembling the 23S rRNA would be as high as or lower than the 
16S rRNA peak, depending on the extend of degradation.  
The theory that DNA contamination accounts for the large 5S peak, was tested by including a 
DNA degradation step into the RNA isolation protocol; although an offset peak connected to 
5S peak in question could be eliminated, this was not the case for the main 5S peak. This 
result indicates that without an extra DNA degradation step, the RNA is slightly 
contaminated with DNA, but that the unexpected 5S peak is not a result of DNA 
contamination.  
The electropherogram of RNA isolated from bacterial cell cultures using the ZR Soil/Fecal 
RNA MicroPrep kit was very similar to that of RNA isolated from fecal samples, ruling out the 
hypothesis that the 5S peak is something specific to fecal samples. Interestingly, RNA 
isolation from feces collected from germ-free mice also displayed an accumulation of 
molecules similar to 5S rRNA in size, which lead to the hypothesis that the large amount of 
small RNA molecules present in the total RNA isolated from fecal samples might be a 
combination of 5S rRNA and tRNA. As the 5S peak is lower, in comparison to the 16S and 23S 
peak, in samples isolated from pure bacterial culture than when isolated from fecal samples, 
the RNA within the 5S rRNA region might partially originate from the host and hasn’t been 
degraded due to the tertiary structure.  
4.1.4.2 Storage of samples for transcriptome analysis 
Factors such as the housing of animals in the animal facility and time required to sampling 
multiple animals, makes it impossible to start isolating RNA immediately after sample 
collection. It was therefore important to determine storage conditions which would have the 
least influence on RNA quality. As a reference, RNA was isolated from a sample collected 
from a mouse in the animal facility immediately stored on ice and transported into the 
laboratory. Simultaneous sampling of multiple mice minimized the time between sample 
collection and RNA isolation and storage on ice reduced possible RNA degradation during 
transport. This is the most optimal way feasible for RNA isolation from fresh fecal samples. 
The RNA retrieved from this reference sample was compared to RNA isolated from samples 
stored in RNAprotect Bacteria for the transport from the animal facility to the lab or natively 
frozen at –80 °C as fast as possible after collection or stored in RNAprotect and frozen at -
80 °C as fast as possible. Freezing samples prior to RNA isolation can minimize the variability 
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between samples isolated in different runs, because samples can be collected and isolated 
simultaneously. The RNA of the reference was comparable to the RNA isolated from samples 
that were stored or frozen in RNAprotect Bacteria prior to RNA isolation, indicating that 
these storage conditions do not substantially impact RNA quality. RNA isolated form fecal 
samples that were natively frozen however, was degraded. For metatranscriptomic analysis 
RNA should therefore either be isolated immediately after sample collection or stored in 
RNAprotect Bacteria until the RNA can be isolated. 
4.1.4.3 RNA stability 
The stability of the RNA was assessed by analyzing the same RNA sample immediately after 
isolation and after one cycle of freezing and thawing on ice, which was enough for slight 
degradation to be apparent. This was indicated by the reduction of the peak height of the 
23S rRNA compared to the 16S rRNA peak and the increase in short RNA strands represented 
by the increased overall baseline level and an even larger peak in the 5S rRNA region. RNA 
samples used for transcriptomic analysis should therefore ideally be reverse transcribed 
immediately after isolation or gone through a maximum of one freezing and thawing cycle. 
In both cases it is important to treat all the samples that will be compared in the same way 
to ensure comparability.  
 Library preparation and 454-sequencing of 16S rRNA amplicons 4.1.5
The composition of a bacterial community can be analyzed on the basis of 16S rRNA gene 
sequences. Depending on the variable region(s) chosen, diversity estimates and 
differentiation of bacteria varies 202,203. The more sequencing information is included into an 
analysis, the more accurate the results are. The 454 sequencing technology was chosen due 
to its superior read length at the beginning of the study; technologies such as Illumina 
however, have improved in the meantime and now also deliver long sequencing reads.  
The literature is not consistent in regards to the discriminating power of the different 
hypervariable regions, although v1-4 (single, or combination of two variable regions) are 
most often mentioned favorably for this application 202–206. Due to the difference in results 
obtained depending upon the hypervariable regions that are analyzed, we would suggest, 
that data comparison should be done cautiously and preferably only with data obtained 
from the same variable regions. For our study, primers spanning the v3 – v6 regions were 
used to create amplicons, which then were sequenced one-sided, starting at the v3 
hypervariable region, on a GS FLX. The mean length of the sequencing reads after removal of 
the barcode and linker sequences and quality trimming, was approximately 300 bp 177. The 
classification of our reads was therefore mostly based on the v3 and v4 hypervariable 
regions. Although Roche is shutting down the 454 platform 207, with the increased read 
length achieved by the Illumina platforms, the combination of v3 and v4 has become one of 
the standard regions examined for analysis of bacterial community compositions 208–211.  
As previously mentioned, the 454 sequencing technology was chosen due to the long 
sequencing reads that were created (up to 700 bp) compared to the much shorter Illumina 
reads (2 x 150 bp for paired end reads in 2012) 149. Taxonomic classification using 16S rRNA 
 Discussion 
 
119 
gene analysis increases in accuracy with sequences length and available sequence 
information in reference databases. As the main goal of the project was to analyze the 
bacterial community composition, it was most important to be able to rely on the taxonomic 
assignment, therefore read length was prioritized. One disadvantage of 454-sequencing is 
the low coverage; at the time of the wetlab experiments, Illumina produced up to 600 Gb 
per run whereas 454 could only sequence 14 Gb per run 149. The coverage, however, can 
easily be adjusted by varying the amount of samples pooled for sequencing or even by 
dividing one sequencing library and sequencing it in two runs, but this significantly increases 
cost.  
Both of these sequencing technologies are based on the sequencing-by-synthesis principal. 
Illumina detects the individual fluorescent label of the incorporated nucleotide, whereas 
Roche detects light signals. Incorporation of nucleotides during synthesis, leads to release of 
pyrophosphate which is transformed into ATP by sulferylase and subsequently converted 
into light by luciferase. The 4 nucleotides are added to the reaction one after the other. The 
number of identical nucleotides added to the synthesized strand is not limited, and each 
additional incorporation increases the light signal. Properties of the light signal therefore 
limit the ability of the platform to detect the addition of multiple nucleotides in one cycle. 
Homopolymer stretches therefore lead to sequencing errors 140,212–214. 
4.2 Microbiome/Metagenome analysis 
 Selection and impact of metadata 4.2.1
After the launch of the first NGS Platform by the company 454 in 2005, an increasing number 
of studies have been performed analyzing various microbiotas in health and disease 
64,65,79,89,215–217. Although the microbiota of various body sites has been analyzed, the 
intestinal microbiome composition has been most commonly associated with disease. Most 
studies have been conducted by comparing samples from healthy people to patients 
affected by diseases of interest. The detected differences therefore do not give any insight 
into whether the microbiota variations are cause or result of disease. In humans the 
microbiota would have to be monitored over long periods of time, and it is very hard to 
predict how many of the individuals participating in a monitoring study will ever develop a 
disease of interest. Animal models with a defined induction of disease, e.g. T-cell transfer or 
the application of chemicals for IBD induction 130,132–135, give the opportunity to define the 
microbiota in a healthy initial state, during development and after manifestation of disease. 
By analyzing the microbiome during the different disease stages, it is possible to determine 
whether changes are the cause or the result of disease. Large inter-individual differences of 
the intestinal microbiota exist, therefore examination of the same individual during different 
phases of health and disease helps to minimize artificial variations of the data resulting from 
strong inter-individual differences 4. When studying the intestinal microbiome, there are two 
main sources for acquiring samples: populations of microbiota associated with mucosa can 
be assessed by taking biopsies, or microorganisms associated with both mucosa and lumen 
can be assessed through the analysis of fecal samples 34. Protocols were established for 
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microbiome analysis from fecal samples to minimize the burden on the study animals; non-
invasive sampling is a major advantage when repeated sampling must be done on the same 
individual.  
Many environmental factors, such as diet, pharmaceutical intervention, age, stress or 
infection, are believed to play an important role in determining the composition of the 
intestinal microbiome 218,219. It has been proposed that these environmental conditions are 
more important in forming the microbiome than genetic background, as the microbiota of 
mono- and dizygotic twins is equally similar 35.  
A wide variety of metadata were collected for the animals included in the study. We 
included as many factors as possible to test for correlation with changes of the microbiota 
composition but also to exclude redundant information to keep the analysis as simple as 
possible. As some factors imply others, for example all animals housed in the same facility 
receive the same food, these were only recorded as one metadata “housing facility”. 
Continuous metadata, as for example the number of living cells isolated from the caecum 
and colon, were combined into groups with similar values for simplified distinction between 
the animals.  
The influence of metadata on the microbial composition was assessed by analyzing whether 
metadata correlated with the clustering of the data. The most obvious correlation was 
established between clustering and animal housing facility, indicating that this had the 
greatest influence. This metadata includes the environment of the housing facility, 
components of the food and water, hygiene state and personal working with the animals, 
which may induce stress and in turn influence the microbiome 220. After separation of the 
data according to the animal facility in which animals were housed, clustering of the data 
correlated with the experiment number. As all experiments ran sequentially, this indicates 
that the environmental conditions changed between the experiments. The strong variation 
between the experiments makes it impossible to compare the results of the different runs, 
because similarities due to treatment protocols were concealed by the strong inter-
experimental variation. Despite the strong variations of the gut microbiome, the clinical 
outcome was the same in the different experiments. This indicates that not only one certain 
composition is responsible for triggering colitis. Also no single bacterial species could be 
associated with disease onset, indicating that something other than the bacterial community 
composition is involved in disease development. 
The human microbiome consortium has determined that large variations seen on a 
taxonomic level do not necessarily imply that the biological functions carried out by the 
microbiome differ 4. As different bacteria can carry out identical (metabolic) functions this 
could be an important fact in colitis development. Analyzing the molecular functions of the 
microbiome may result in less variation between the mice of the different experiments 
which in turn could lead to identification of factors of the microbiome that influence colonic 
inflammation. 
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 Differences between PCoA (Principal Coordinates Analysis) results computed by 4.2.2
Qiime and Megan: 
The first analysis of the sequencing data, using Qiime for PCoA, revealed differences 
between the Endohi and Endolo mice (Figure 27). A separation of the samples collected from 
the animals according to the animal facility where they were housed, was apparent. The 
clustering of samples within Endohi or Endolo animals indicated that they were more similar 
within one group than the groups were to each other. The PCoA analysis also displayed three 
sub-clusters of Endohi animals. This finding suggested that the microbiota of some animals 
were more similar to each other than others. The PCoA analysis created using Megan, 
however, did not show the same clustering patterns (Figure 27). The compositions of the 
intestinal microbiome of Endolo animals were not more similar within this group than 
compared to Endohi animals. Different factors are responsible for the contrasting results; 
two factors with large impact on the results are:  
1. Qiime PCoA analysis creates plots including the 3 principal components responsible for 
the largest variation between the samples. Our Megan PCoA only considered two principal 
components simultaneously for calculating the similarity of multiple samples.  
2. The sequencing reads are grouped into OTUs (Orthologous Taxonomic Units) according to 
sequence similarity and a phylogenetic tree is built from this information. The Qiime PCoA 
analysis was calculated from the OTUs, which contain sequences that were 97 % identical. 
Phylogenic trees were created, and the distances between two samples were then 
calculated. In contrast, the PCoA analysis performed by Megan was based on a taxonomic 
tree built after taxonomic binning of the sequencing reads 177. Sequences grouped into 
different OTUs were not necessarily associated with different taxonomies and were 
therefore considered to be the same (as described in Figure 81) in the Megan analysis. The 
basis for calculation of the similarities between samples is therefore different for the Qiime 
and Megan analysis and can lead to different results.  
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Figure 81: Qiime uses a OTU based phylogenetic tree especially created for the sequencing data for PCoA 
whereas PCoA calculated by Megan is based on a taxonomic association. As different OTUs may be associated 
to the same taxon, the phylogenetic trees used for calculation of similarities can differ. 
Multivariate analyses are widely used for cluster analysis and comparing microbiota 
compositions 13,36,90,194,221–223. It has to be kept in mind however, that the relationships 
between large amounts of datasets are simplified and projected onto only two or three 
dimensions, which leads to loss of information.  
Metagenomic analysis addresses the question of which differences are responsible for 
deviating clinical phenotypes by correlating taxonomic and functional information with 
sequencing data. The goal is to determine which microorganisms are responsible for disease, 
and/or which microbiome-specific physiologic functions are missing, acquired, or increased 
in the microorganisms and influence the patients’ health.  
As the revealed community structure and function analysis strongly depend on the analysis 
methods used and on how the underlying data has been processed, the analysis pipeline 
must be adapted to the problem one wants to solve. 
For analyzing which metadata factors influence the observed clustering of our data we 
decided to use the PCoA created by Qiime. Qiime has two properties that guided our 
decision: first, it is specific to our experiment, because the phylogenetic trees were created 
using our actual sequencing data, and second, three principal components were considered 
simultaneously. As more components were considered, we received a more refined 
clustering.  
 Impact of metadata on clustering: 4.2.3
Analysis of the microbiome prior to T-cell transfer showed that the separation of Endohi and 
Endolo mice is most prominent. The data did not cluster according to other factors, such as 
treatment, sampling time or disease outcome. After selection of samples belonging to the 
same cluster (e.g. Endohi), however, clustering according to the experiment number is 
apparent. This demonstrates that,  if one wants to detect components of the microbiome 
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important for health and disease, it is important to select data that is comparable according 
to the metadata and thereby simplify analysis and reveal otherwise obscured results.  
After analyzing all varieties of metadata in our experiment it became apparent that animals 
first clustered depending upon their housing facility, and then according to the experiment 
in which they were included. This indicates that the differences due to treatment are less 
than differences related to environmental factors between the experiments themselves. This 
was unexpected and undesirable, as it meant that differences between groups in different 
experiments could not be compared. The large number of experiments in this study could 
not be conducted simultaneously. Because of the sequential nature of the experimental set 
up, animals in the different experiments may have been exposed to different environmental 
conditions leading to changes of the composition of the intestinal microbiota. Our results 
indicate, that these differences between the experiments impact the microbiome to a larger 
extend than the different types of treatment.  
Accepting that the environmental influence of housing was the most predominant factor, 
this variable was eliminated from analyses by only comparing data of animals within the 
same experiments. This would allow prominent influences from other metadata to be 
unmasked. Although this decreased effective sample sizes, analyses of the remaining 
variables of interest, such as treatment group, included only the samples collected from 
animals of the same or a comparable experiment that had clustered in the first analysis.  
Our data show that, for microbiome analysis, it is important to run the experiments of 
groups one wants to compare to each other, simultaneously. This measure will reduce the 
influence of environmental factors on the results and differences seen between groups are 
more likely to be related to disease outcome. The large variations of the microbiome 
composition of individuals indicate that large group sizes are necessary to distinguish 
between physiologic and causative differences. If experiments can’t be performed in parallel 
(e.g. due to a limited number of available animals), it is important to verify that the results 
are comparable before analyzing them. This can be done for example by comparing the 
initial microbiomes of animal belonging to the same group but run in separate experiments. 
A second measure that can be taken to reduce differences between animals is using 
offspring of the same mice. As the microbiome is transferred from the mother to the 
newborns 224and they share a cage for the first 3 weeks, siblings should be inoculated and 
exposed to the same microorganisms. 
 Bacterial gut community and its effect on the host 4.2.4
Clinical experimental outcome was classified on the basis of the histological score (Table 17). 
As expected Endohi Rag1-/- mice developed colitis after reconstitution of the T-cell 
population, while Endolo animals remained healthy and displayed no signs of inflammation. 
The PCoA analysis distinguished two clusters for the Endohi animals. One cluster consisted of 
samples collected prior to T-cell transfer, and the other included the samples collected from 
the same mice later during the experiment. This revealed that the bacterial composition of 
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the animals developing colitis seemed to change drastically within the first 3 weeks post T-
cell transfer. A new stable bacterial community was established in the inflamed gut, which 
did not continue to change during the remainder of the experiment.  
In contrast, the intestinal microbiome of the Endolo animals showed only slight variations 3 
weeks after T-cell transfer, and returned to a composition very similar to the initial one by 
the end of the study. These results indicate that the microbiome of Endolo animals is stable, 
specific for healthy animals, and promotes the maintenance of homoeostasis. The slight 
variation of the microbiome during the first three weeks of the experiment might be the 
result of factors such as the following:  
1. Stress can influence the bacterial colonization of the intestine 225. The process of T-cell 
transfer is very stressful for the animals, which could impact the composition of the 
microbiota. This potential stress reaction variable could be investigated in future studies by 
analyzing changes of the intestinal microbiome of mice as a result of exposure to stress. 
2. The host immune system and the bacteria colonizing the intestine interact with each 
other 33,34,64. As Rag1-/- mice lack B- and T-cells, they do not have a functional adaptive 
immune response. With the introduction of T-cells, immune reactions that could not occur 
prior to T-cell reconstitution, could then take place. This interaction could result in the slight 
shift of the microbiota until a stable state was reached, than the original composition 
resurfaces.  
Published studies associating diseases with certain microbial compositions usually cannot 
answer whether the variations between healthy and diseased individuals are the cause or 
result of disease due to the experimental setup (no longitudinal analysis, just a comparison 
of healthy and affected individuals) 226.  
Our work demonstrates that genetically identical mice react differently to transfer of naïve 
T-cells depending upon the composition of the intestinal microbiome. The outcome of our 
experiments suggests that the intestinal bacteria play an important role in colitis induction. 
This hypothesis is strengthened by further experiments showing that by changing the 
composition of bacteria colonizing the mouse intestine, the development of colitis after 
T-cell transfer can be induced or prevented. This is reciprocal: the changes of the bacterial 
composition occurring during disease development also indicate that disease affects the 
microbiome. This is not surprising, as bacterial fitness and survival depend highly upon 
environmental conditions, such as an altered pH, which change vastly in an inflamed gut 
51,227.  
The PCoA analysis of all analyzed samples showed that in some cases the microbiome of 
animals developing colitis is very similar to that of animals maintaining homoeostasis, and in 
other cases animals with the same disease state have very different microbiota. This 
indicates, that the composition determined by our 16S rRNA gene sequencing assay is not 
sufficient to classify a given microbiota as colitogenic or not.  
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One possible explanation for the apparent similarity of the microbiomes of animals which 
will develop colitis and those which will maintain homoeostasis may simply be a result of the 
sequencing not being deep enough. That is, there may not be sufficient amounts of 
sequencing reads per sample to detect very low abundance species, which can greatly 
impact the host 228. If this is the case in our model, then the bacterial species responsible for 
disease development might be under the detection limit and was not found in the analysis. 
Deeper sequencing could give more insight into this issue. This can either be done by pooling 
fewer samples for a 454 sequencing run, or switching to the Illumina system which produces 
much more sequences per run and with advances in technology is now able to produce 
longer read lengths as well. 
One difference seen in the microbiome of Endohi and Endolo mice is the presence of 
Akkermansia. One species, Akkermansia muciniphilia, is known to degrade mucus 229. One 
could assume that this would negatively affect the barrier function of the gut, as the mucus 
is important for preventing intestinal bacteria from infecting the host. However, the 
presence of Akkermansia muciniphila has been linked to healthy individuals. The reason for 
this might be that this bacterial strain produces high amounts of butyrate, which is used as 
an energy source by the epithelial cells and therefore promotes barrier integrity of the 
gut85,229,230. 
Due to the great complexity of the samples, for group comparisons the dimensions had to be 
reduced by PCoA. Only the three components accounting for the greatest variations among 
samples were considered for analyzing and grouping the samples. This analysis is therefore 
based on the assumption that the experimental outcome is a result of the components 
responsible for the greatest variations between the samples. If only two factors could 
possibly influence clustering of samples, a graph showing both factors could be created and 
clustering would be apparent. Due to the high complexity of the microbiome data however, 
a simple visualization of the data is impossible. Therefor we have to except a tradeoff: For 
visualization and cluster analysis, dimensions have to be reduced, therefore not all factors 
are considered, and some important variables clustering the data into the desired groups 
may be lost if they do not account for high variability.   
Feeding E. coliWT to Endo
lo animals prior to T-cell transfer resulted in the development of 
disease. We demonstrated that the endotoxicity of the intestinal microbiom is important for 
colitis induction. The wild-type E. coli strain is known to be highly endotoxic 183, suggesting, 
that the feeding of this bacterial strain increases the endotoxicity of the microbiome to a 
level which leads to pathology. On the other hand, treating Endohi animals with the low 
endotoxic E. coliMUT strain prevents colitis, suggesting that the overall endotoxicity is lowered 
and does not induce inflammation. Importantly, the results were confirmed after feeding 
mice purified wild-type and mutant LPS. The intestinal microbial community composition of 
mice developing disease was not the same in all the mice treated for colitis induction, and no 
bacterial strain could consistently be linked to inflammation. This leads to the hypothesis, 
that the overall endotoxicity of the different communities may predispose mice to disease, 
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and be higher in mice prone to disease compared to those maintaining homeostasis. This 
thesis is supported by the fact that feeding purified LPS with different endotoxicities is 
sufficient to induce or prevent inflammation. Whether the molecules directly interact with 
the host or if they influence the gut community, which then in turn influences the host, 
however, still remains to be elucidated. 
Wild-type and mutant E. coli strains can both be detected in Endohi animals on the day of T-
cell transfer. Whereas sequencing reads assigned to the genus of Escherichia are detectable 
at all three time points in samples collected from the mice fed with the wild-type strain, the 
samples from Endohi animals fed with the mutant strain contained no Proteobacteria reads, 
but from week 3 on many Bacteroidetes reads were found. 
Before T-cell transfer, the Endohi animal were treated with antibiotics and subsequently fed 
with E. coliWT and E. coliMUT. Antibiotics reduce the amount of native bacteria in the 
gastrointestinal tract, leading the introduced bacteria that are fed to the mice to be present 
in the gut in a high proportion and can therefore be detected in the 16S microbiome 
analysis. The amount of Escherichia detected in Endohi mice fed with E. coliWT increases 
during the first 3 weeks. This can be ascribed to the constant feeding of E. coliWT in 
combination with growth of introduced bacteria that have colonized the gut. After week 3, 
the proportion of reads associated with E. coli was reduced although the amount of bacteria 
that were fed to the mice did not decrease. At the same time, reads were correlated to 
Tenericutes and other bacteria that were not previously detected. The evident growth of 
these bacteria is either a result of the changing conditions during inflammation of the gut or 
due to regeneration of native bacteria after antibiotic treatment. Another possibility is that 
the growing amount of Escherichia in the gut directly or indirectly positively influenced the 
growth of these other bacteria. As the sequencing reads only describe the proportions of 
bacterial species within the gut and not the absolute amount of bacteria, this decrease in 
reads associated with Escherichia does not imply that the absolute amount of Escherichia 
also decreases after week 3.  
As analysis by NGS detects all bacteria present within a sample, it could be argued that the 
Escherichia detected are only from fed bacteria that are passing through the gut, not from 
bacteria colonizing the gut. If this were the case, however, we would expect to see the same 
amount of reads belonging to Escherichia in the group of animals fed the mutant strain. As 
this is not the case, it is assumed that in contrast to the mutant strain, E. coliWT was able to 
colonize the intestine of the Endohi mice.  
Other groups have described differences of the microbiota during IBD and in a healthy state 
118–120. Most described differences were correlated to Firmicutes and Bacteroidetes. 
Manichanh et al., noted a loss of diversity in Crohn’s disease, which was mainly due to far 
fewer OTUs associated to the Firmicutes phylum 118. Our results did not indicate loss of 
diversity resulting from inflammation. An equal number of genera were detected in mice 
prior to and during inflammation. It is possible that in order to see an overall loss of 
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diversity, the experiments would have had to be run over a longer time period after onset of 
inflammation. Environmental conditions within the gut change during disease, and while 
many bacteria can survive, some bacteria are better equipped than others to cope with an 
altered environment. Selection of these bacteria and their subsequent expansion in turn can 
alter the conditions for the remaining bacteria. These factors can lead to a less diverse 
microbiome over time. Even if a reduction of diversity has taken place, this might not 
immediately be visible by NGS analysis, because this method does not distinguish between 
DNA isolated from viable or dead bacteria. Therefore bacterial species can be detected, even 
if they are no longer an active part of the intestinal microbiome and until all bacterial 
residues have passed through the gut, the diversity detected by NGS will be overestimated. 
Some publications have connected colitis development with the genera of Bacteroides or 
Bifidobacterium, as well as single bacterial species such as F. prausnitzii 77,124,125,231,232. In our 
study, no bacterial species or groups could be consistently linked to development of colitis. 
Changing the initial composition of the intestinal microbiota, however, resulted in the 
prevention or induction of colitis. This indicates that the intestinal microbiota plays a crucial 
role in colitis development and maintenance of homeostasis. It is possible that not one strain 
of bacteria is responsible for the development of inflammation, but instead combinations of 
bacteria that were not recognized as being involved in this process as a group. As the 
endotoxicity of the gut microbiome seems to be important, it is possible that a collection of 
high endotoxic bacteria are increased in Endohi mice compared to Endolo mice, but this is not 
statistically significant for the single bacteria and therefore not evident in our analysis. 
The great differences seen between data described in different publications and our own 
must be compared with caution. Sequencing results are dependent upon the sample 
handling and methods used for DNA extraction, sequencing and analysis 233. Selection bias 
may be introduced at various levels: different DNA extraction methods extract DNA better 
from certain microorganisms than from others 180,194, detected phylogenetic association 
varies depending upon the variable region of the 16S rRNA gene analyzed 203, and OTU 
grouping is influenced by the selected algorithms and thresholds and taxonomic 
classification depends on the information stored in the database used as reference.  
Due to the preparation of the DNA for sequencing (e.g. PCR prior to 454 and Illumina-
sequencing) and the specifications of the different sequencing techniques and chemistries 
(Table 2), the sequencing results vary between the various sequencing platforms. This can 
also lead to different taxonomic classification during subsequent database comparison.    
 Influence of the host on bacterial gut community 4.2.5
The changes of the microbial composition during colitis development (Figure 32) indicate 
that inflammation impacts the composition of the microbial community within the intestine. 
This shows that, when comparing the microbiomes of healthy individuals and those suffering 
from IBD, the microbiome differences are not likely to be the cause of disease. We would 
suggest that the differences are due to a combination of an initial microbiota that promotes 
inflammation, which in turn induces changes of the bacterial gut community. In order to 
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identify microbial compositions capable of triggering onset of disease it is therefore 
necessary to perform longer-term studies. Longitudinal studies must include enough 
subjects that some will potentially develop disease. Studying the microbiome during 
different stages of disease (prior to disease development as well as during its onset and 
progression) can allow the identification of microbial communities involved in promoting or 
preventing disease. If certain community members or functions can be identified, microbial 
screenings as described for colorectal cancer by Zackular et al. 234 can be utilized for 
improving non-invasive preventive medical examination. 
4.3 Functional microbiome analyses – Metagenomics & -transcriptomics 
Analysis of the bacterial composition was used for detection of differences within the 
intestinal bacterial population in different health conditions. We saw large inter-individual 
variability of our 16S metagenomics data and no certain bacterial species could be linked to 
induction of colitis or manifested disease. The Human Microbiome Consortium found that 
variation of the community members within the microbiota does not necessarily lead to 
differences within the (metabolic) functions of the bacteria 4. Some functions are necessary 
for survival and thus are carried out by all bacteria. Other genes are “nice to have” because 
they lead to increased fitness of the microbes in certain environmental conditions. As genes 
can be transferred between different organisms, the phylogenetic composition cannot be 
correlated to biological tasks that are carried out. Additionally, Arumugam et al. 36 found 
that high abundance functions can be performed by a variety of low abundance species. 
Even if these functions were unambiguously connected to defined bacterial species, the limit 
of detection would have to be very low to identify those species as a driving force.  
Methods that are available for functional analysis include shotgun metagenomics and 
metatranscriptomics. The genomic DNA of the microbiota gives information on which 
biological tasks can potentially be performed by the members of the microbiota; studying 
the RNA answers the question which genes are in use. The levels of mRNA and regulatory 
RNAs, such as miRNA or siRNA indicate up- or down regulation of genes.  
The intestinal microbiota clearly plays an important role in colitis induction. However, the 
16S metagenomics data do not indicate a specific bacterial species to be responsible for 
disease development, suggesting that the crucial difference is on the functional level.  
Besides the aforementioned differences between shotgun metagenomics and 
metatranscriptomics, the stability of the DNA and RNA molecules influence the results. Most 
RNA molecules are very unstable, which both complicates working with the RNA and limits 
the detection of residual RNA molecules from prior disease stages. The stability of DNA 
isolated from dead bacteria that had not yet cleared the mouse intestine, but were no 
longer able to interact with the host could contribute to the  similarity of the 16S 
metagenomics results of treated and untreated mice housed under identical conditions.  
 Discussion 
 
129 
Definition of functions carried out by the intestinal microbiome and its interaction with the 
host in health and disease is an important step on the way to prevent and heal IBD. 
Functional analysis can therefore help to identify targets for IBD treatment.  
4.4 Verification of sequencing data 
In this project we used FISH to verify the sequencing results with respect to Bacteroides and 
Enterobacteriaceae. FISH was chosen because it is independent of PCR and can directly 
detect various bacterial strains without prior cultivation. However, differences were often 
seen between the sequencing and FISH results.  
According to the sequencing results, the intestinal microbiomes of T-cell transferred Endohi 
animals and E. coliWT treated Endo
lo animals contain Enterobacteriaceae, but these were not 
detected by FISH. Innate properties of the technique mean that the identification of single 
bacteria by FISH is only possible if the bacteria are separated from each other, but this 
reduces the number of bacteria that are analyzed by this method. The lower the number of 
bacteria analyzed, the lower the probability of detecting rare bacterial species. The 
sequencing data showed very low read counts for Enterobacteriaceae in the T-cell 
transferred Endohi animals and E. coliWT treated Endo
lo mice, indicating low amounts of 
Enterobacteriaceae specific 16S rRNA genes. As the detection limit of NGS (depending on 
sequencing depth) is lower than that of FISH, it is not surprising that rare bacteria were only 
detected by NGS. 
A second issue that might account for the differences found between the amplicon 
sequencing results and FISH could be that by FISH, only viable bacteria are detected. Our 
probes target 16S rRNA, which is distributed in the cytoplasm of the bacteria, allowing the 
bacteria to be visualized using a fluorescence microscope. Dead bacteria that no longer 
contain enough intact rRNA are not detected. DNA, however, is much more stable than RNA, 
and it is therefore possible that sequencing also detects sequences from dead bacteria and 
they are treated as part of the current intestinal microbiota. Bacterial DNA that was ingested 
by the mice and not degraded enough while passing the GIT would also be detected by NGS 
but not by FISH. 
Hybridization of the Bacteroides probe was detected for all samples collected from Endolo 
mice, irrespective of treatment. The NGS results, however, did not confirm the FISH results. 
No sequencing reads were assigned to the genus Bacteroides, however all the samples 
contained high amounts of sequencing reads that were mapped to the order Bacteroidales. 
The mapping of the reads to the corresponding taxon was performed using a LCA (lowest 
common ancestor) algorithm. If a read mapped to two different reference strains with a 
similar score, the read was mapped to the taxon that is the lowest common ancestor of the 
two reference strains. The NGS results therefore do not necessarily mean that the sample 
did not contain Bacteroides, but that Bacteroides sequences could not be clearly 
distinguished from sequences of other bacteria belonging to the family Bacteroideaceae.  
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The differences between the results of the two methods may also be method unrelated; the 
bacteria are not uniformly distributed within the gut 19–21, therefore it is likely that the 
microbial composition varies as the feces passes through the intestine. Instead of being 
collected as defecated pellets, the fecal samples collected in week 6 were taken directly 
from the intestine after the mice were sacrificed. Samples collected for the first two time 
points for NGS had passed through the gut completely, whereas samples for FISH were 
extracted from more proximal parts of the gut. The more or less incomplete passage of the 
fecal samples used for FISH could therefore also be responsible for variations between the 
NGS data and the FISH results. 
FISH was selected to verify our NGS results because it is a PCR independent method and no 
cultivation of bacteria is necessary. The differences of NGS and FISH results, however, 
indicate that FISH may not be suitable as a reference. Using just these two methods is not 
sufficient to discriminate if the results differ due to technical reasons or due to false 
bacterial identification of NGS. In addition, FISH can only verify the presence or absence of 
defined bacterial strains, whereas amplicon sequencing will also detect unknown bacteria.  
Due to technical differences FISH can be used to verify that bacteria detected by amplicon 
sequencing are viable and present in a sample; however, if bacteria are not detected by FISH 
this does not necessarily imply that amplicon sequencing produces false positive results. 
Cultivation of bacteria could verify presence of rare bacteria but this method is limited to 
bacteria that can be cultivated in the lab. Another possibility to verify the results of amplicon 
sequencing would be by PCR. However, as our NGS approach is also based on PCR, the 
methods could be biased in the same way. These methods can only be used to identify 
known bacteria; verification of the sequencing results with these methods is therefore 
limited. FISH and other methods can be used to verify certain parts of the bacterial 
composition, but their limitations have to be considered as none of them can completely 
verify the sequencing results. In some cases, a combination of different methods might be 
the best strategy. It also has to be recognized that NGS is not perfect and therefore not only 
limitations of other methods are responsible for variations of results, but that errors of 
amplicon sequencing and subsequent bioinformatic analysis can also account for 
differences. 
4.5 Conclusions 
The protocols developed here can be used for analyzing the microbiome from fecal samples 
using next-generation sequencing. However, this work also shows that different measures 
should be taken to increase the impact of these kinds of studies. First, the experiments for 
microbiome analyses should be done in one large study rather than multiple, serial, smaller 
experiments to reduce environmental influences on the results. Cohousing of animals prior 
to the experiments, irrespective of the later treatment, may also help to minimize 
differences in the native microbiota between the animals of individual cages and increase 
the chance of identifying responsible microorganisms.  
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Using siblings, or offspring of sisters can minimize the maternal effect and reduce differences 
between the individual animals. Housing the animals in isolators, can also contribute to a 
maintaining the microbiota of the animals as the influence of environmental factors is 
limited. It is also important to ensure that all the metadata are represented by a sufficient 
amount of animals in order to analyze the influence of the different aspects. As some may 
not be predictable, it is important to include enough extra individuals at the same time 
however, consider if the prospective benefit justifies larger cohort sizes.   
As the sequencing method and chemistry also strongly impact the results, it is important to 
ensure, that these do not change during the course of the experiments. One should also 
make sure that the same reference data sets were used for all the data that will be 
compared. 
If microbiome analysis is done for the first time on a new type of sample and the magnitude 
of number of microorganisms or genes is unknown it is helpful to perform a pilot study with 
a small amount of individuals. Analyzing the rarefaction curve of the sequencing data will 
indicate, how many reads per sample should be sequenced or in other words how deep 
sequencing should be. 
Bacteria are not the only microorganisms that may be of interest, when correlating a 
microbiome to different phenotypes. In addition to this, the functions the microbiota may 
also be important for disease development and they are not necessarily correlated to the 
microorganisms present. In many cases it is therefore advisable to perform shotgun 
sequencing instead of 16S analysis. This will also give a better resolution of the data, because 
bacteria can usually be identified down to the species or even subspecies level whereas 16S 
analysis can normally only identify bacteria down to the genus level.  
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Figure 82: Composition of the intestinal microbiome of Endohi mice (n=7; all mice were part of experiment 3) 
before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the class level, the row in the 
middle on the order level and the last row on the family level. Reads that could not be assigned, were declared 
as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, 
the more reads were associated with the corresponding taxon. 
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Figure 83: Composition of the intestinal microbiome of Endolo mice (n=5; all mice were part of experiment 4) 
before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the class level, the row in the 
middle on the order level and the last row on the family level. Reads that could not be assigned, were declared 
as “others” of the lowest taxonomic level possible. The figures were created using Paver. The darker the color, 
the more reads were associated with the corresponding taxon. 
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Figure 84: Composition of the intestinal microbiome of E. coliWT pretreated Endohi mice (n=2; all mice were 
part of experiment 3) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the 
class level, the row in the middle on the order level and the last row on the family level. Reads that could not 
be assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 85: Composition of the intestinal microbiome of E. coliWT pretreated Endolo mice (n=5; all mice were 
part of experiment 4) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the 
class level, the row in the middle on the order level and the last row on the family level. Reads that could not 
be assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 86: Composition of the intestinal microbiome of E. coliMUT pretreated Endohi mice (n=2; all mice were 
part of experiment 3) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the 
class level, the row in the middle on the order level and the last row on the family level. Reads that could not 
be assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 87: Composition of the intestinal microbiome of E. coliMUT pretreated Endolo mice (n=5; all mice were 
part of experiment 4) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the 
class level, the row in the middle on the order level and the last row on the family level. Reads that could not 
be assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 88: Composition of the intestinal microbiome of LPSWT pretreated Endohi mice (n=3; all mice were part 
of experiment 7) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the class 
level, the row in the middle on the order level and the last row on the family level. Reads that could not be 
assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 89: Composition of the intestinal microbiome of LPSWT pretreated Endolo mice (n=4; all mice were part 
of experiment 4) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the class 
level, the row in the middle on the order level and the last row on the family level. Reads that could not be 
assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 90: Composition of the intestinal microbiome of LPSMUT pretreated Endohi mice (n=5; all mice were 
part of experiment 3) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the 
class level, the row in the middle on the order level and the last row on the family level. Reads that could not 
be assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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Figure 91: Composition of the intestinal microbiome of LPSMUT pretreated Endolo mice (n=4; all mice were 
part of experiment 4) before, 3 or 6 weeks post T-cell transfer. The top row shows the composition on the 
class level, the row in the middle on the order level and the last row on the family level. Reads that could not 
be assigned, were declared as “others” of the lowest taxonomic level possible. The figures were created using 
Paver. The darker the color, the more reads were associated with the corresponding taxon. 
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